var title_f32_8_32896="Management of tMN";
var content_f32_8_32896=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F79891&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F79891&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 627px\">",
"   <div class=\"ttl\">",
"    Management of therapy-related myeloid neoplasm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 607px; height: 573px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Larson RA. Etiology and management of therapy-related myeloid leukemia. Hematology Am Soc Hematol Educ Program 2007; 2007:453.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_8_32896=[""].join("\n");
var outline_f32_8_32896=null;
var title_f32_8_32897="Tubal ring sterilization A";
var content_f32_8_32897=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F62868&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F62868&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tubal ring sterilization by laparoscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 331px; height: 370px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The tube is grasped 2 to 3 cm distal to the tubal junction prior to releasing the Falope ring.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William Mann, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_8_32897=[""].join("\n");
var outline_f32_8_32897=null;
var title_f32_8_32898="Patient information: Radiculopathy (The Basics)";
var content_f32_8_32898=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/83823\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/51/4917\">",
"         Anatomy of the back",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?40/62/41954\">",
"         Patient information: Herniated disc (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?36/7/36978\">",
"         Patient information: Low back pain in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?22/31/23026\">",
"         Patient information: Neck pain (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?39/44/40642\">",
"         Patient information: Spinal stenosis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?16/45/17106\">",
"         Patient information: Whiplash (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?8/47/8950\">",
"         Patient information: Low back pain in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?26/35/27188\">",
"         Patient information: Neck pain (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Radiculopathy (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/radiculopathy-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H1685406769\">",
"      <span class=\"h1\">",
"       What is radiculopathy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Radiculopathy is the medical term for the pain, numbness, or tingling that occurs when nerves coming from the spinal cord get pinched or damaged. Radiculopathy can affect different parts of the body, depending on which nerve or group of nerves is affected. People sometimes refer to radiculopathy as having a &ldquo;pinched nerve.&rdquo;",
"     </p>",
"     <p>",
"      Here are 2 common examples of radiculopathy:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Cervical radiculopathy",
"        </strong>",
"        &ndash; People with this type of radiculopathy have pain, numbness, or tingling down 1 or both arms. The condition happens when 1 or more of the nerves that go from the spine to the arm get pinched or damaged.",
"       </li>",
"       <li>",
"        <strong>",
"         Lumbosacral radiculopathy",
"        </strong>",
"        &ndash; People with this type of radiculopathy have pain, numbness, or tingling in the buttocks or down the leg. The condition happens when 1 or more of the nerves that go from the spine to the foot and leg get pinched or damaged. (People sometimes refer to the symptoms of this type of radiculopathy as &ldquo;sciatica.&rdquo;)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1685406784\">",
"      <span class=\"h1\">",
"       What causes radiculopathy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Radiculopathy is usually caused by a problem with the back. To understand radiculopathy, it&rsquo;s helpful to first learn a little about the back and spine.",
"     </p>",
"     <p>",
"      The back is made up of (",
"      <a class=\"graphic graphic_figure graphicRef56246 \" href=\"mobipreview.htm?4/51/4917\">",
"       figure 1",
"      </a>",
"      ):",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Vertebrae &ndash; A stack of bones that sit on top of 1 another like a stack of coins. Each of these bones has a hole in the center. When stacked, the bones form a hollow tube that protects the spinal cord.",
"       </li>",
"       <li>",
"        Spinal cord and nerves &ndash; The spinal cord is the highway of nerves that connects the brain to the rest of the body. It runs through the vertebrae. Nerves branch from the spinal cord and pass in between the vertebrae. From there they connect to the arms, the legs, and the organs. (This is why problems in the back can cause leg pain or bladder problems.)",
"       </li>",
"       <li>",
"        Discs &ndash; Rubbery discs sit in between each of the vertebrae to add cushion and allow movement. The discs that sit between the vertebrae have a tough outer shell and jelly-like center.",
"       </li>",
"       <li>",
"        Muscles, tendons, and ligaments &ndash; Together the muscles, tendons, and ligaments are called the \"soft tissues\" of the back. These soft tissues support the back and help hold it together.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Radiculopathy can happen when changes in the back cause a nerve to get pinched or damaged. This can happen if:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        The vertebrae form bumps called bone spurs, which press on nearby nerves. (People with a condition called &ldquo;spinal stenosis&rdquo; often have this problem.)",
"       </li>",
"       <li>",
"        The discs between the vertebrae dry up and shrink, so that the space between the vertebrae gets smaller. This causes nerves to get pinched.",
"       </li>",
"       <li>",
"        The discs between the vertebrae break open and spill out, causing them to press on or irritate nearby nerves. (A disc that breaks open and spills is called a &ldquo;herniated disc.&rdquo;)",
"       </li>",
"       <li>",
"        Other medical conditions, such as diabetes, infection, inflammation, or a tumor injure the nerves near the spinal cord.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1685406799\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have new pain, numbness, or tingling that seems to spreads out to your arms or legs from your spine, see a doctor or nurse.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1685406814\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Maybe. Doctors can tell a lot about a person&rsquo;s radiculopathy based on which parts of the body are affected and how. Because of that, you might not need any tests, especially if you have had symptoms only for a short time. Still, if your doctor or nurse is concerned about nerve damage, he or she might order 1 or more of these tests:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Imaging tests &ndash; Imaging tests, such as X-rays, MRIs, or CT scans, create pictures of the inside of the body. These imaging tests can show problems with the back like those described above.",
"       </li>",
"       <li>",
"        Electromyography (also called &ldquo;EMG&rdquo;) &ndash; During this test, a technician checks how well electrical pulses travel across nerves to the part of your body that has symptoms. The test helps show whether the nerves controlling that body part are working right.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1685406829\">",
"      <span class=\"h1\">",
"       How is radiculopathy treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Many people with radiculopathy do not need formal treatment. In some cases, the radiculopathy goes away as the back and nerves heal. In other cases, people find ways to cope with their symptoms.",
"     </p>",
"     <p>",
"      When people do get treatment, the treatments can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pain medicines that you can get without a prescription (If these do not work, stronger prescription pain medicines are available.)",
"       </li>",
"       <li>",
"        Medicines to relax the muscles (called muscle relaxants)",
"       </li>",
"       <li>",
"        Injections of medicines that numb the back or reduce swelling",
"       </li>",
"       <li>",
"        Physical therapy to learn special exercises and stretches",
"       </li>",
"       <li>",
"        Spinal manipulation, which is when someone like a physical therapist (exercise expert) or a chiropractor moves or \"adjusts\" the joints of your back",
"       </li>",
"       <li>",
"        Acupuncture, which is when someone who knows traditional Chinese medicine inserts tiny needles into your body to block pain signals",
"       </li>",
"       <li>",
"        Massage",
"       </li>",
"       <li>",
"        Surgery to repair the problem causing symptoms",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1685406844\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/31/23026?source=see_link\">",
"       Patient information: Neck pain (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/45/17106?source=see_link\">",
"       Patient information: Whiplash (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/7/36978?source=see_link\">",
"       Patient information: Low back pain in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?40/62/41954?source=see_link\">",
"       Patient information: Herniated disc (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/44/40642?source=see_link\">",
"       Patient information: Spinal stenosis (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?26/35/27188?source=see_link\">",
"       Patient information: Neck pain (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/47/8950?source=see_link\">",
"       Patient information: Low back pain in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?32/8/32898?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83823 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-189.41.172.26-E56BECDC24-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_8_32898=[""].join("\n");
var outline_f32_8_32898=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1685406769\">",
"      What is radiculopathy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1685406784\">",
"      What causes radiculopathy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1685406799\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1685406814\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1685406829\">",
"      How is radiculopathy treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1685406844\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/83823\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/51/4917\">",
"      Anatomy of the back",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?40/62/41954?source=related_link\">",
"      Patient information: Herniated disc (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/47/8950?source=related_link\">",
"      Patient information: Low back pain in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/7/36978?source=related_link\">",
"      Patient information: Low back pain in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?26/35/27188?source=related_link\">",
"      Patient information: Neck pain (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/31/23026?source=related_link\">",
"      Patient information: Neck pain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/44/40642?source=related_link\">",
"      Patient information: Spinal stenosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/45/17106?source=related_link\">",
"      Patient information: Whiplash (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_8_32899="Vulva hematoma with drain";
var content_f32_8_32899=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F70417&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F70417&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Closure of large vulvar hematoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note drain left in place due to fact that this was a contaminated wound.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Emans SJ, Laufer MR. Emans, Laufer &amp; Goldstein&rsquo;s Pediatric&nbsp;and Adolescent Gynecology, 6th ed, Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_8_32899=[""].join("\n");
var outline_f32_8_32899=null;
var title_f32_8_32900="Dicyclomine (dicycloverine): Patient drug information";
var content_f32_8_32900=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Dicyclomine (dicycloverine): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/6/27749?source=see_link\">",
"     see \"Dicyclomine (dicycloverine): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?16/22/16740?source=see_link\">",
"     see \"Dicyclomine (dicycloverine): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F159572\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Bentyl&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F159573\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Bentylol&reg;;",
"     </li>",
"     <li>",
"      Dicyclomine Hydrochloride Injection;",
"     </li>",
"     <li>",
"      Formulex&reg;;",
"     </li>",
"     <li>",
"      Jamp-Dicyclomine;",
"     </li>",
"     <li>",
"      Protylol;",
"     </li>",
"     <li>",
"      Riva-Dicyclomine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10012099\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691853",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat GI (gastrointestinal) spasms.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat irritable bowel syndrome.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10012098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not give this drug to an infant younger than 6 months of age.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701940",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to dicyclomine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703534",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Enlarged prostate, glaucoma, bowel block, myasthenia gravis, or trouble passing urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10012103\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10012104\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10012106\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10012101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695839",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take 30 to 60 minutes before meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694356",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (syrup) if you cannot swallow pills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695985",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10012102\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10012107\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10012108\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12376 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-210.101.131.232-6DA085BC69-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_8_32900=[""].join("\n");
var outline_f32_8_32900=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159572\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159573\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012099\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012098\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012103\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012104\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012106\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012101\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012102\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012107\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012108\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?27/6/27749?source=related_link\">",
"      Dicyclomine (dicycloverine): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?16/22/16740?source=related_link\">",
"      Dicyclomine (dicycloverine): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_8_32901="Small bowel diverticula";
var content_f32_8_32901=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Small bowel diverticula",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/8/32901/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/8/32901/contributors\">",
"     Vladan Milovic, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/8/32901/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/8/32901/contributors\">",
"     J Thomas LaMont, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/8/32901/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/8/32901/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/8/32901/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 29, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diverticulae, sac-like protrusions of the bowel wall, occur throughout the small and large bowel. The presence of these lesions should be considered in patients with unexplained gastrointestinal bleeding, intestinal obstruction, acute abdomen, chronic abdominal pain, anemia, or malabsorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/1\">",
"     1",
"    </a>",
"    ]. Large bowel diverticula are more frequent and more often present with a complication.",
"   </p>",
"   <p>",
"    This topic review will focus on small bowel diverticula with the exception of Meckel's diverticulum. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/52/29513?source=see_link&amp;anchor=H19#H19\">",
"     \"Diagnostic approach to lower gastrointestinal bleeding in children\", section on 'Meckel's diverticulum'",
"    </a>",
"    .) The epidemiology and pathophysiology of colonic diverticular disease, the treatment of diverticulitis, and diverticular bleeding are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/63/36854?source=see_link\">",
"     \"Epidemiology and pathophysiology of colonic diverticular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/8/13450?source=see_link\">",
"     \"Treatment of acute diverticulitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/49/38679?source=see_link\">",
"     \"Colonic diverticular bleeding\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H544330926\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small bowel diverticula occur most frequently in the duodenum where they are usually asymptomatic. In one retrospective review of 208 patients, diverticula were located in the duodenum in 79 percent, in the jejunum or ileum in 18 percent, and in all three segments in 3 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/2\">",
"     2",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    Complications occurred in 46 percent of jejunoileal diverticula compared to only 13 percent of duodenal diverticula.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DUODENAL DIVERTICULA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Duodenal diverticula have been found in 2 to 5 percent of patients undergoing",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    studies of the upper gastrointestinal tract, and in 7 percent of a series of 1735 patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/3\">",
"     3",
"    </a>",
"    ]. They can be either extraluminal or rarely intraluminal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Extraluminal diverticula",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vast majority of duodenal diverticula are extraluminal. They tend to occur near the papilla of Vater; in one study, for example, 61 percent were within 2 cm of the papilla [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/3\">",
"     3",
"    </a>",
"    ]. They are thought to be acquired as a result of herniation through a defect caused by the entrance of large vessels.",
"   </p>",
"   <p>",
"    Fewer than 10 percent are ever symptomatic and only about 1 percent will require definite treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/4\">",
"     4",
"    </a>",
"    ]. For these reasons, there is no indication for prophylactic removal, and an initial trial of conservative therapy is usually indicated in the symptomatic patient.",
"   </p>",
"   <p>",
"    Extraluminal duodenal diverticula are associated with a higher frequency of common bile duct stones than seen in a control ERCP population without diverticula [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/3\">",
"     3",
"    </a>",
"    ]. The stones are often pigment stones and are thought to be related to bacterial contamination of the biliary tree due to stasis within the diverticula [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/5\">",
"     5",
"    </a>",
"    ]. The bacteria deconjugate bilirubin glucuronide, which predisposes to pigment stones.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H544331056\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obstruction, food impaction, perforation, and bleeding are rare complications of extraluminal duodenal diverticula [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Diverticulitis can occur, typically presenting with midepigastric or periumbilical pain, nausea, and fever.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H544331063\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis is usually not suspected clinically. CT scan may show a soft tissue mass or debris or an abscess in the peripancreatic region [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H544331070\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;As a small percentage of extraluminal diverticula are symptomatic (less than 10 percent), there is no indication for prophylactic removal. An initial trial of conservative therapy (observation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    antibiotics if related to diverticulitis) is usually indicated in the symptomatic patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Intraluminal diverticula",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraluminal diverticula are rare and usually congenital. They often arise as a sac near the papilla of Vater; they are connected to part or all of the wall of the duodenum and extend distally. Intraluminal diverticula are lined on both sides with duodenal mucosa and an eccentric opening is usually proximal in the sac. They result from incomplete canalization of the intestinal lumen after the embryonic proliferative epithelial stage, producing a duodenal diaphragm or web [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H544331077\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Affected patients are often asymptomatic. The most common symptoms are abdominal pain and intestinal obstruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H544331084\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis can be made endoscopically, although the endoscopic view can be misinterpreted as showing pyloric channel stenosis since an obstructed and dilated duodenum may look similar to the antrum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/8\">",
"     8",
"    </a>",
"    ]. An upper gastrointestinal series, showing the typical appearance of a",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    -filled globular structure, may be required to confirm the diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H544331091\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Duodenotomy and excision are usually necessary for removal, although endoscopic surgery has also been successful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     JEJUNOILEAL DIVERTICULA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Jejunoileal diverticula occur in 1 to 2 percent of the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/2\">",
"     2",
"    </a>",
"    ]. They are usually multiple and localized to the proximal jejunum. They are often asymptomatic and should not be removed prophylactically, although complications have been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. A retrospective study of 112 patients with small intestinal diverticula, found the following types of presentations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Incidental finding &ndash; 42 percent; at almost five years of follow-up, over 80 percent of these remained asymptomatic.",
"     </li>",
"     <li>",
"      Mild to moderate abdominal complaints &ndash; 40 percent had malabsorption or chronic pain; at a mean follow-up of 6.5 years, 46 percent were cured with conservative therapy.",
"     </li>",
"     <li>",
"      Emergent complications &ndash; 18 percent, one-half of whom required surgery.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Jejunoileal diverticula may be composed of mucosa and submucosa only, or of all layers of the jejunal wall. They are frequently associated with disorders of intestinal motility, such as progressive systemic sclerosis, visceral neuropathies, and myopathies. In patients with visceral myopathy, atrophy of the jejunal wall from one side and increased luminal pressure from the other may lead to the protrusion of the small intestinal mucosa through the defects in the lamina muscularis mucosae, resulting in the formation of small intestinal diverticula [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/12\">",
"     12",
"    </a>",
"    ]. Familial aggregation has been described in case series suggesting that some cases may be heritable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Jejunoileal diverticula are asymptomatic in 42 percent of individuals.",
"     </li>",
"     <li>",
"      The major clinical manifestation of jejunoileal diverticula is malabsorption due to bacterial overgrowth.",
"     </li>",
"     <li>",
"      Early satiety, bloating, and chronic upper abdominal discomfort can be found in approximately 40 percent of cases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/15\">",
"       15",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/45/11990?source=see_link\">",
"       \"Clinical manifestations and diagnosis of small intestinal bacterial overgrowth\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inflammation, bleeding, and perforation are far less common than in colonic diverticular disease. In one series of 112 patients with a clinical diagnosis of jejunoileal diverticulosis, perforation was observed in 5 percent, GI bleeding in 2 percent, and diverticulitis in less than 1 percent of patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/11\">",
"       11",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Obscure intestinal bleeding can be the only clinical symptom [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/16\">",
"       16",
"      </a>",
"      ]. Rarely, massive small bowel bleeding has been reported secondary to diverticulitis with ulceration, diverticulosis with associated trauma, or arteriovenous malformations. Bleeding may also result from rupture of a jejunal diverticulum into the lumen [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/17-19\">",
"       17-19",
"      </a>",
"      ]. These patients present with hematochezia but may also present with melena and hematemesis.",
"      <br/>",
"      <br/>",
"      Perforation is a rare complication and usually presents as acute abdominal pain in the elderly [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/20\">",
"       20",
"      </a>",
"      ]. Although 6 of 13 were known to have jejunal diverticula, the diagnosis of perforation was made preoperatively in only two cases.",
"     </li>",
"     <li>",
"      Patients have also presented with an acute abdomen associated with acute jejunal diverticulitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A number of individual reports and small series have described unusual complications associated with small bowel diverticula. Examples include an ileo-abdominal fistula caused by penetration of an ileal diverticulum [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/22\">",
"       22",
"      </a>",
"      ], entrapment of the capsule in patients undergoing wireless capsule endoscopy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/23\">",
"       23",
"      </a>",
"      ], and episodes of intestinal pseudoobstruction, volvulus, perforation, and small bowel obstruction secondary to enterolith impaction, which appear to occur more often than previously known [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/24-27\">",
"       24-27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of jejunoileal diverticulosis is often made incidentally. The onset of malabsorption syndrome in an elderly patient without any past medical history to suggest other entities can point to jejunoileal diverticulosis as the underlying cause.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     Barium",
"    </a>",
"    follow-through and enteroclysis are the diagnostic methods of choice. Barium follow-through studies may also show an accompanying jejunal dyskinesia. CT scan usually reveals a mass with an air-fluid collection in contiguity with small bowel loops [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients with unexplained upper gastrointestinal bleeding after negative upper gastrointestinal endoscopy, angiography may reveal leakage into the small intestinal lumen originating from the jejunal diverticula. However, in most cases of diverticulitis or massive bleeding, the diagnosis of jejunal diverticula is not established before exploratory laparotomy is performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/11,30\">",
"     11,30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with malabsorption due to bacterial overgrowth caused by stasis within the diverticula are treated with antibiotics. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/50/28454?source=see_link\">",
"       \"Treatment of small intestinal bacterial overgrowth\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Open or laparoscopic-assisted resection of the involved segment is indicated in patients with jejunoileal diverticulitis, bowel perforation, or bleeding.",
"     </li>",
"     <li>",
"      Complication rates are usually low with these procedures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/11,15\">",
"       11,15",
"      </a>",
"      ]; however, in one series, postoperative complications were noted to have occurred more commonly in the symptomatic patients (26 percent) than in patients in which diverticula were found incidentally during surgery (8 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/31\">",
"       31",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In patients with small intestinal diverticulosis complicated by enterolith impaction, enterotomy and stone extraction or manual crushing and milking the stone distally into the colon have been successful [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32901/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Small bowel diverticula occur most frequently in the duodenum. They have been found in 2 to 5 percent of patients undergoing",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      studies of the upper gastrointestinal tract, and in 7 percent undergoing endoscopic retrograde cholangiopancreatography (ERCP). The vast majority of duodenal diverticula are extraluminal. (See",
"      <a class=\"local\" href=\"#H544330926\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fewer than 10 percent of extraluminal duodenal diverticula are ever symptomatic. Obstruction, food impaction, perforation, and bleeding are rare complications. These diverticula are also associated with a higher frequency of common bile duct stones. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Duodenal diverticula'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Jejunoileal diverticula occur in 1 to 2 percent of the general population. They are frequently associated with disorders of intestinal motility, such as progressive systemic sclerosis, visceral neuropathies, and myopathies. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Jejunoileal diverticula'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      The major clinical manifestation of jejunoileal diverticula is malabsorption due to bacterial overgrowth. However, a variety of rare complications have been reported. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with small bowel diverticula who are asymptomatic, we suggest observation only (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). &nbsp;",
"     </li>",
"     <li>",
"      Bacterial overgrowth can be treated with antibiotics. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/50/28454?source=see_link\">",
"       \"Treatment of small intestinal bacterial overgrowth\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Specific interventions may be required in patients who have complications attributable to the diverticula. For intraluminal duodenal diverticula, duodenotomy and excision are usually necessary for removal, although endoscopic surgery has also been successful.",
"      <br/>",
"      <br/>",
"      Complications of jejunal diverticula including jejunoileal diverticulitis, bowel perforation, or bleeding, may require open or laparoscopic-assisted resection of the involved segment.",
"      <br/>",
"      <br/>",
"      In patients with small intestinal diverticulosis complicated by enterolith impaction, enterotomy and stone extraction or manual crushing and milking the stone distally into the colon have been successful. (See",
"      <a class=\"local\" href=\"#H544331070\">",
"       'Treatment'",
"      </a>",
"      above.) &nbsp; &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/1\">",
"      Longo WE, Vernava AM 3rd. Clinical implications of jejunoileal diverticular disease. Dis Colon Rectum 1992; 35:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/2\">",
"      Akhrass R, Yaffe MB, Fischer C, et al. Small-bowel diverticulosis: perceptions and reality. J Am Coll Surg 1997; 184:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/3\">",
"      Leivonen MK, Halttunen JA, Kivilaakso EO. Duodenal diverticulum at endoscopic retrograde cholangiopancreatography, analysis of 123 patients. Hepatogastroenterology 1996; 43:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/4\">",
"      Psathakis D, Utschakowski A, M&uuml;ller G, et al. Clinical significance of duodenal diverticula. J Am Coll Surg 1994; 178:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/5\">",
"      Miyazawa Y, Okinaga K, Nishida K, Okano T. Recurrent common bile duct stones associated with periampullary duodenal diverticula and calcium bilirubinate stones. Int Surg 1995; 80:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/6\">",
"      Macari M, Faust M, Liang H, Pachter HL. CT of jejunal diverticulitis: imaging findings, differential diagnosis, and clinical management. Clin Radiol 2007; 62:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/7\">",
"      Fleming CR, Newcomer AD, Stephens DH, Carlson HC. Intraluminal duodenal diverticulum. Report of two cases and review of the literature. Mayo Clin Proc 1975; 50:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/8\">",
"      Blam ME, Metz DC. Image of the month. A wind sock web deformity of the proximal duodenum. Gastroenterology 2000; 119:292, 602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/9\">",
"      Abbassi-Ghadi N, Bartlam K, Rasheed S, Holme T. A case of obscure gastrointestinal bleeding in a teenager. Ann R Coll Surg Engl 2009; 91:W1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/10\">",
"      Lempinen M, Salmela K, Kemppainen E. Jejunal diverticulosis: a potentially dangerous entity. Scand J Gastroenterol 2004; 39:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/11\">",
"      Tsiotos GG, Farnell MB, Ilstrup DM. Nonmeckelian jejunal or ileal diverticulosis: an analysis of 112 cases. Surgery 1994; 116:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/12\">",
"      Krishnamurthy S, Kelly MM, Rohrmann CA, Schuffler MD. Jejunal diverticulosis. A heterogenous disorder caused by a variety of abnormalities of smooth muscle or myenteric plexus. Gastroenterology 1983; 85:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/13\">",
"      Koch AD, Schoon EJ. Extensive jejunal diverticulosis in a family, a matter of inheritance? Neth J Med 2007; 65:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/14\">",
"      Andersen LP, Schjoldager B, Halver B. Jejunal diverticulosis in a family. Scand J Gastroenterol 1988; 23:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/15\">",
"      Palder SB, Frey CB. Jejunal diverticulosis. Arch Surg 1988; 123:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/16\">",
"      Yang CW, Chen YY, Yen HH, Soon MS. Successful double balloon enteroscopy treatment for bleeding jejunal diverticulum: a case report and review of the literature. J Laparoendosc Adv Surg Tech A 2009; 19:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/17\">",
"      Wilcox RD, Shatney CH. Massive rectal bleeding from jejunal diverticula. Surg Gynecol Obstet 1987; 165:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/18\">",
"      Spiegel RM, Schultz RW, Casarella WJ, Wolff M. Massive hemorrhage from jejunal diverticula. Radiology 1982; 143:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/19\">",
"      Mendonca HL, Vieta JO, Ling WS. Jejunal diverticulosis with massive hemorrhage. Am J Gastroenterol 1978; 70:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/20\">",
"      Chendrasekhar A, Timberlake GA. Perforated jejunal diverticula: an analysis of reported cases. Am Surg 1995; 61:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/21\">",
"      Novak JS, Tobias J, Barkin JS. Nonsurgical management of acute jejunal diverticulitis: a review. Am J Gastroenterol 1997; 92:1929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/22\">",
"      Eriguchi N, Aoyagi S, Nakayama T, et al. Ileo-abdominal wall fistula caused by diverticulum of the ileum. J Gastroenterol 1998; 33:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/23\">",
"      Gaba RC, Schlesinger PK, Wilbur AC. Endoscopic video capsules: radiologic findings of spontaneous entrapment in small intestinal diverticula. AJR Am J Roentgenol 2005; 185:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/24\">",
"      Chiu KW, Changchien CS, Chuah SK. Small-bowel diverticulum: is it a risk for small-bowel volvulus? J Clin Gastroenterol 1994; 19:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/25\">",
"      Harris LM, Volpe CM, Doerr RJ. Small bowel obstruction secondary to enterolith impaction complicating jejunal diverticulitis. Am J Gastroenterol 1997; 92:1538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/26\">",
"      Lobo DN, Braithwaite BD, Fairbrother BJ. Enterolith ileus complicating jejunal diverticulosis. J Clin Gastroenterol 1999; 29:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/27\">",
"      Kongara KR, Soffer EE. Intestinal motility in small bowel diverticulosis: a case report and review of the literature. J Clin Gastroenterol 2000; 30:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/28\">",
"      Lough E, Richmond B, Maxwell D, Hayes JD. Obstructing phytobezoar arising from proximal jejunal diverticulum. Am J Surg 2008; 195:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/29\">",
"      Gayer G, Zissin R, Apter S, et al. Acute diverticulitis of the small bowel: CT findings. Abdom Imaging 1999; 24:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/30\">",
"      Vernava AM 3rd, Moore BA, Longo WE, Johnson FE. Lower gastrointestinal bleeding. Dis Colon Rectum 1997; 40:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32901/abstract/31\">",
"      Yoon YS, Park IJ, Lee KH, et al. [Should small bowel diverticula be removed?]. Korean J Gastroenterol 2004; 44:275.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2539 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-201.211.0.116-235EC14115-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_8_32901=[""].join("\n");
var outline_f32_8_32901=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H544330926\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DUODENAL DIVERTICULA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Extraluminal diverticula",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H544331056\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H544331063\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H544331070\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Intraluminal diverticula",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H544331077\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H544331084\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H544331091\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      JEJUNOILEAL DIVERTICULA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/45/11990?source=related_link\">",
"      Clinical manifestations and diagnosis of small intestinal bacterial overgrowth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/49/38679?source=related_link\">",
"      Colonic diverticular bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/52/29513?source=related_link\">",
"      Diagnostic approach to lower gastrointestinal bleeding in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/63/36854?source=related_link\">",
"      Epidemiology and pathophysiology of colonic diverticular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/8/13450?source=related_link\">",
"      Treatment of acute diverticulitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/50/28454?source=related_link\">",
"      Treatment of small intestinal bacterial overgrowth",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_8_32902="Accommodative esotropia";
var content_f32_8_32902=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F57340&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F57340&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Refractive-type accommodative esotropia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 364px; height: 520px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Esotropia of the left eye. B) Esotropia is eliminated with the use of hyperopic glasses.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Tasman W, Jaeger E. The Wills Eye Hospital Atlas of Clinical Ophthalmology, 2e. Lippincott Williams &amp; Wilkins, 2001. Copyright &copy;2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_8_32902=[""].join("\n");
var outline_f32_8_32902=null;
var title_f32_8_32903="Oxymorphone: Drug information";
var content_f32_8_32903=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Oxymorphone: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?31/36/32325?source=see_link\">",
"    see \"Oxymorphone: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5709189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F205317\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Opana&reg;;",
"     </li>",
"     <li>",
"      Opana&reg; ER",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F205335\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Analgesic, Opioid",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F205321\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Analgesia:",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     Dosage must be individualized.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.M., SubQ: Initial: 1-1.5 mg; may repeat every 4-6 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Labor analgesia: I.M.: 0.5-1 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Initial: 0.5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Immediate release:",
"     </b>",
"     Acute pain:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Opioid-naive:",
"     </i>",
"     Initial: 5-10 mg every 4-6 hours as needed (American Pain Society, 2008). Dosage adjustment should be based on level of analgesia, side effects, pain intensity, and patient comorbidities.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Currently on stable dose of parenteral oxymorphone:",
"     </i>",
"     Approximately 10 times the total daily parenteral requirement. The calculated total oral daily amount should be given in 4-6 equally divided doses.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Currently on other opioids:",
"     </i>",
"     Use standard conversion chart to convert total daily dose of current opioid to oxymorphone equivalent. Generally start with one-half (",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     ) the calculated total daily oxymorphone dosage and administer in divided doses every 4-6 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Extended release (Opana&reg; ER):",
"     </b>",
"     Chronic pain:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Opioid-naive:",
"     </i>",
"     Initial: 5 mg every 12 hours. Supplemental doses of immediate-release oxymorphone may be used as &ldquo;rescue&rdquo; medication as dosage is titrated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Continued requirement for supplemental dosing may be used to titrate the dose of extended-release continuous therapy. Adjust therapy incrementally, by 5-10 mg every 12 hours at intervals of every 3-7 days. Ideally, scheduled (basal) dosage may be titrated to generally mild pain or no pain with the regular use of fewer than 2 supplemental doses per 24 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Currently on stable dose of parenteral oxymorphone:",
"     </i>",
"     Approximately 10 times the total daily parenteral requirement. The calculated total oral daily amount should be given in 2 divided doses (for every 12-hour oxymorphone extended release dosing).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Currently on opioids:",
"     </i>",
"     Use conversion chart (see",
"     <b>",
"      \"Note\"",
"     </b>",
"     ) to convert daily dose of current opioid to oxymorphone equivalent. Generally start with one-half (",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     ) the calculated daily oxymorphone dosage. Divide daily dose in 2 (for every 12-hour oxymorphone extended release dosing) and round down to nearest dosage strength.",
"     <b>",
"      Note:",
"     </b>",
"     Per manufacturer, the following approximate oral dosages are equivalent to a daily dose of oxymorphone 10 mg:",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:8em;text-align:justify;\">",
"     Hydrocodone 20 mg",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:8em;text-align:justify;\">",
"     Oxycodone 20 mg",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:8em;text-align:justify;\">",
"     Methadone 20 mg (methadone has a long half-life and accumulates; ratio can vary widely)",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:8em;text-align:justify;\">",
"     Morphine 30 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Conversion of stable dose of immediate-release oxymorphone to extended-release oxymorphone:",
"     </i>",
"     Use same total daily dose. Administer one-half (",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     ) of the daily dose of immediate-release oxymorphone (Opana&reg;) as the extended-release formulation (Opana&reg; ER) every 12 hours",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F205322\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"     <b>",
"      Note:",
"     </b>",
"     Initiate dosing at the lower end of the dosage range.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F3274032\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;50 mL/minute: Reduce initial dosage of oral and parenteral formulations (bioavailability increased 57% to 65%). Begin therapy at lowest dose and titrate slowly with careful monitoring.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F3274033\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Mild impairment: Initiate with lowest possible dose and titrate slowly with careful monitoring.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Moderate-to-severe impairment: Use is contraindicated.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F205300\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Opana&reg;: 1 mg/mL (1 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride: 5 mg, 10 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Opana&reg;: 5 mg, 10 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, extended release, oral, as hydrochloride: 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Opana&reg; ER: 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F205284\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes injection solution",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F205337\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-II",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F13646620\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and as follows, must be dispensed with this medication:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Opana&reg; ER:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM283820.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM283820.pdf",
"     </a>",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F3274035\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Oral: Administer immediate release and extended release tablets 1 hour before or 2 hours after eating. Opana&reg; ER tablet should be swallowed whole; do not break, crush, dissolve, or chew.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F205343\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Glycopyrrolate, hydroxyzine, ranitidine.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F205303\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral: Management of moderate-to-severe acute pain; analgesia during labor; preoperative medication; anesthesia support; relief of anxiety in patients with dyspnea associated with pulmonary edema secondary to acute left ventricular failure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral, regular release: Management of moderate-to-severe acute pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral, extended release: Management of moderate-to-severe pain in patients requiring around-the-clock opioid treatment for an extended period of time",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F205345\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Oxymorphone may be confused with oxycodone, oxymetholone",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F205333\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Incidence usually on higher end with extended release (ER) tablet.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Somnolence (9% to 19%), dizziness (7% to 18%), fever (1% to 14%), headache (7% to 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Pruritus (8% to 15%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (19% to 33%), constipation (4% to 28%), vomiting (9% to 16%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypotension (&lt;10%), tachycardia (&lt;10%), edema (&lt;10%), flushing (&lt;10%), hypertension (&lt;10%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Anxiety (1% to &lt;10%), sedation (1% to &lt;10%), depression (&lt;10%), disorientation (&lt;10%), lethargy (&lt;10%), nervousness (&lt;10%), restlessness (&lt;10%), fatigue (&le;4%), insomnia (&le;4%), confusion (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Dehydration (&lt;10%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal distension (&lt;10%), flatulence (1% to &lt;10%), xerostomia (1% to &lt;10%), dyspepsia (&lt;10%), weight loss (&lt;10%), diarrhea (&le;4%), abdominal pain (&le;3%), appetite decreased (&le;3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Weakness (&lt;10%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Blurred vision (&lt;10%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Hypoxia (&lt;10%), dyspnea (&lt;10%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis (1% to &lt;10%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Agitation, allergic reaction, apnea (injection), atelectasis (injection), biliary colic, bradycardia, bronchospasm (injection), clamminess,  dermatitis, diplopia (injection), dysphoria, euphoric mood, hallucination, hot flashes, hypersensitivity, ileus, injection site reaction, micturition difficulty, miosis, oliguria (injection), orthostatic hypotension, palpitation, physical and psychological dependence, respiratory depression, syncope, TTP (inappropriate injection of ER tablet); ureteral spasm (injection), urinary retention, urticaria",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F205306\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to oxymorphone, other morphine analogs (phenanthrene derivatives), or any component of the formulation; paralytic ileus (known or suspected); moderate-to-severe hepatic impairment; severe respiratory depression (unless using immediate release or parenteral formulation in monitored setting with resuscitative equipment); acute/severe bronchial asthma; hypercarbia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Parenteral formulation is also contraindicated in the treatment of upper airway obstruction and pulmonary edema due to a chemical respiratory irritant.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F205288\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypotension: May cause hypotension; use with caution in patients with hypovolemia, cardiovascular disease (including acute MI), or with drugs which may exaggerate hypotensive effects (including phenothiazines or general anesthetics).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Phenanthrene hypersensitivity: Due to structural similarities, hypersensitivity to other phenanthrene-derivative opioid agonists (codeine, hydrocodone, hydromorphone, levorphanol, morphine) may result in similar hypersensitivity reaction if oxymorphone is used; therefore, the use of oxymorphone is contraindicated in patients with previous hypersensitivity to other phenanthrene derivatives.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thrombotic thrombocytopenic purpura (TTP): Cases of TTP resulting in kidney failure (requiring dialysis) and death have been reported as a result of misuse by drug abusers injecting the extended-release tablets intravenously. Tablets are intended for oral administration only.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Abdominal conditions: May obscure diagnosis or clinical course of patients with acute abdominal conditions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adrenal insufficiency: Use with caution in patients with adrenal insufficiency, including Addison's disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Biliary tract impairment: Use with caution in patients with biliary tract dysfunction including acute pancreatitis; may cause constriction of sphincter of Oddi.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression/coma: Use with caution in patients with CNS depression or coma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug abuse: Use with caution in patients with a history of drug abuse or acute alcoholism; potential for drug dependency exists. Tolerance, psychological and physical dependence may occur with prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Head trauma: Use with extreme caution in patients with head injury, intracranial lesions, or elevated intracranial pressure (ICP); exaggerated elevation of ICP may occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with mild hepatic dysfunction; use is contraindicated in moderate-to-severe impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Obesity: Use with caution in patients who are morbidly obese.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia/urinary stricture: Use with caution in patients with prostatic hyperplasia and/or urinary stricture.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Psychosis: Use with caution in patients with toxic psychosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory disease: Use with caution in patients with pre-existing respiratory compromise (hypoxia and/or hypercapnia), COPD or other obstructive pulmonary disease, and kyphoscoliosis or other skeletal disorder which may alter respiratory function; critical respiratory depression may occur, even at therapeutic dosages.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorders: Use with caution in patients with seizure disorders.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid dysfunction: Use with caution in patients with thyroid dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; MAO inhibitors: Use not recommended within 14 days of MAO inhibitors; severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Debilitated patients: Use with caution in debilitated patients; there is a greater potential for critical respiratory depression, even at therapeutic dosages.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; may be more sensitive to adverse effects. Decrease initial dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Extended release: Opana&reg; ER:",
"     <b>",
"      [U.S. Boxed Warnings]: Opana&reg; ER is an extended release oral formulation of oxymorphone and is not suitable for use as an &ldquo;as needed&rdquo; analgesic. Tablets should not be broken, chewed, dissolved, or crushed; tablets should be swallowed whole.",
"     </b>",
"     Opana&reg; ER is intended for use in long-term, continuous management of moderate-to-severe chronic pain. It is not indicated for use in the immediate postoperative period (12-24 hours).",
"     <b>",
"      [U.S. Boxed Warning]: The coingestion of ethanol or ethanol-containing medications with Opana&reg; ER may result in accelerated release of drug from the dosage form, abruptly increasing plasma levels, which may have fatal consequences.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Abuse/misuse/diversion:",
"     <b>",
"      [U.S. Boxed Warning]: Healthcare provider should be alert to problems of abuse, misuse, and diversion.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Optimal regimen: An opioid-containing analgesic regimen should be tailored to each patient's needs and based upon the type of pain being treated (acute versus chronic), the route of administration, degree of tolerance for opioids (naive versus chronic user), age, weight, and patient comorbidities. The optimal analgesic dose varies widely among patients; doses should be titrated to pain relief/prevention.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Withdrawal: Concurrent use of agonist/antagonist analgesics may precipitate withdrawal symptoms and/or reduced analgesic efficacy in patients following prolonged therapy with mu opioid agonists. Abrupt discontinuation following prolonged use may also lead to withdrawal symptoms.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299807\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F205293\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alvimopan: Analgesics (Opioid) may enhance the adverse/toxic effect of Alvimopan. This is most notable for patients receiving long-term (i.e., more than 7 days) opiates prior to alvimopan initiation.  Management: Alvimopan is contraindicated in patients receiving therapeutic doses of opioids for more than 7 consecutive days immediately prior to alvimopan initiation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: May increase the excretion of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May enhance the analgesic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): May enhance the hypotensive effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Analgesics (Opioid) may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: Oxymorphone may enhance the adverse/toxic effect of MAO Inhibitors.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mixed Agonist / Antagonist Opioids: May diminish the analgesic effect of Analgesics (Opioid). Management: Seek alternatives to mixed agonist/antagonist opioids in patients receiving pure opioid agonists, and monitor for symptoms of therapeutic failure/high dose requirements (or withdrawal in opioid-dependent patients) if patients receive these combinations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: Analgesics (Opioid) may diminish the therapeutic effect of Pegvisomant.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: Analgesics (Opioid) may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Succinylcholine: May enhance the bradycardic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Analgesics (Opioid) may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F205314\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Ethanol ingestion with extended-release tablets is specifically contraindicated due to possible accelerated release and potentially fatal overdose. Ethanol may also increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: When taken orally with a high-fat meal, peak concentration is 38% to 50% greater. Both immediate-release and extended-release tablets should be taken 1 hour before or 2 hours after eating.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: Avoid valerian, St John's wort, kava kava, gotu kola (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F205295\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F3273604\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Teratogenic effects were not observed in animal studies; however, decreased fetal weight, decreased litter size, increased stillbirths, and increased neonatal death were noted. Chronic opioid use during pregnancy may lead to a withdrawal syndrome in the neonate. Symptoms include irritability, hyperactivity, loss of sleep pattern, abnormal crying, tremor, vomiting, diarrhea, weight loss, or failure to gain weight.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F205325\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F12806095\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Some opioids can be found in breast milk. Withdrawal symptoms may be observed in breast-feeding infants when opioid analgesics are discontinued.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F3274034\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Immediate release and extended release tablets should be taken 1 hour before or 2 hours after eating.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F5989447\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Opana Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 mg/mL (1 mL): $3.13",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, 12-hour",
"     </b>",
"     (Opana ER (Crush Resistant) Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (60): $143.56",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     7.5 mg (60): $209.60",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (60): $275.66",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     15 mg (60): $382.28",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (60): $488.93",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     30 mg (60): $703.73",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     40 mg (60): $918.54",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, 12-hour",
"     </b>",
"     (Oxymorphone HCl ER Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (100): $181.26",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     7.5 mg (100): $264.65",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (100): $348.06",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     15 mg (100): $482.69",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (100): $617.33",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     30 mg (100): $888.54",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     40 mg (100): $1159.78",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Opana Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (100): $359.75",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (100): $653.21",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Oxymorphone HCl Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (100): $294.61",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (100): $534.93",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F205297\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Respiratory rate, heart rate, blood pressure, CNS activity",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F205287\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oxymorphone hydrochloride is a potent narcotic analgesic with uses similar to those of morphine. The drug is a semisynthetic derivative of morphine (phenanthrene derivative) and is closely related to hydromorphone chemically (Dilaudid&reg;).",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F205305\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Parenteral: 5-10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Analgesic: Parenteral: 3-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : I.V.: 1.94-4.22 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 10% to 12%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via glucuronidation to active and inactive metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Oral: ~10%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Oral: Immediate release: 7-9 hours; Extended release: 9-11 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (&lt;1% as unchanged drug); feces",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Adams MP and Ahdieh H, &ldquo;Pharmacokinetics and Dose-Proportionality of Oxymorphone Extended Release and its Metabolites: Results of a Randomized Crossover Study,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2004, 24(4):468-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/8/32903/abstract-text/15098800/pubmed\" id=\"15098800\" target=\"_blank\">",
"        15098800",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Adams MP and Ahdieh H, &ldquo;Single- and Multiple-Dose Pharmacokinetic and Dose-Proportionality Study of Oxymorphone Immediate-Release Tablets,&rdquo;",
"      <i>",
"       Drugs R D",
"      </i>",
"      , 2005, 6(2):91-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/8/32903/abstract-text/15777102/pubmed\" id=\"15777102\" target=\"_blank\">",
"        15777102",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Drugs for Pain,&rdquo;",
"      <i>",
"       Med Lett Drugs Ther",
"      </i>",
"      , 2000, 42(1085):73-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/8/32903/abstract-text/10951654/pubmed\" id=\"10951654\" target=\"_blank\">",
"        10951654",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gabrail NY, Dvergsten C, and Ahdieh H, &ldquo;Establishing the Dosage Equivalency of Oxymorphone Extended Release and Oxycodone Controlled Release in Patients With Cancer Pain: A Randomized Controlled Study,&rdquo;",
"      <i>",
"       Curr Med Res Opin",
"      </i>",
"      , 2004, 20(6):911-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/8/32903/abstract-text/15200750/pubmed\" id=\"15200750\" target=\"_blank\">",
"        15200750",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gimbel J and Ahdieh H, &ldquo;The Efficacy and Safety of Oral Immediate-Release Oxymorphone for Postsurgical Pain,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2004, 99(5):1472-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/8/32903/abstract-text/15502051/pubmed\" id=\"15502051\" target=\"_blank\">",
"        15502051",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gimbel J, Walker D, Ma T, et al, &ldquo;Efficacy and Safety of Oxymorphone Immediate Release for the Treatment of Mild to Moderate Pain After Ambulatory Orthopedic Surgery: Results of a Randomized, Double-Blind, Placebo-Controlled Trial,&rdquo;",
"      <i>",
"       Arch Phys Med Rehabil",
"      </i>",
"      , 2005, 86(12):2284-9",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/8/32903/abstract-text/16344024/pubmed\" id=\"16344024\" target=\"_blank\">",
"        16344024",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Matsumoto AK, Babul N, and Ahdieh H, &ldquo;Oxymorphone Extended-Release Tablets Relieve Moderate to Severe Pain and Improve Physical Function in Osteoarthritis: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase III Trial,&rdquo;",
"      <i>",
"       Pain Med",
"      </i>",
"      , 2005, 6(5):357-66.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/8/32903/abstract-text/16266356/pubmed\" id=\"16266356\" target=\"_blank\">",
"        16266356",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McIlwain H and Ahdieh H, &ldquo;Safety, Tolerability, and Effectiveness of Oxymorphone Extended Release for Moderate to Severe Osteoarthritis Pain: A One-Year Study,&rdquo;",
"      <i>",
"       Am J Ther",
"      </i>",
"      , 2005,  12(2):106-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/8/32903/abstract-text/15767827/pubmed\" id=\"15767827\" target=\"_blank\">",
"        15767827",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain,&rdquo; 6th ed, Glenview, IL: American Pain Society, 2008.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Prommer E, &ldquo;Oxymorphone: A Review,&rdquo;",
"      <i>",
"       Support Care Cancer",
"      </i>",
"      , 2006, 14(2):109-15.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/8/32903/abstract-text/16317569/pubmed\" id=\"16317569\" target=\"_blank\">",
"        16317569",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rathmell JP, Viscomi CM, and Ashburn MA, &ldquo;Management of Nonobstetric Pain During Pregnancy and Lactation,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 1997, 85(5):1074-87.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/8/32903/abstract-text/9356103/pubmed\" id=\"9356103\" target=\"_blank\">",
"        9356103",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sinatra RS and Harrison DM, &ldquo;Oxymorphone in Patient-Controlled Analgesia,&rdquo;",
"      <i>",
"       Clin Pharm",
"      </i>",
"      , 1989, 8(8):541, 544.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/8/32903/abstract-text/2475287/pubmed\" id=\"2475287\" target=\"_blank\">",
"        2475287",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zacher JL and Givone DM, &ldquo;False-Positive Urine Opiate Screening Associated With Fluoroquinolone Use,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2004, 38:1525-28.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/8/32903/abstract-text/15252190/pubmed\" id=\"15252190\" target=\"_blank\">",
"        15252190",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9733 Version 48.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-5CB361C86E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_8_32903=[""].join("\n");
var outline_f32_8_32903=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5709189\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205317\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205335\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205321\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205322\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3274032\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3274033\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205300\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205284\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205337\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13646620\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3274035\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205343\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205303\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205345\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205333\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205306\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205288\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299807\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205293\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205314\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205295\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3273604\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205325\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12806095\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3274034\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5989447\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205297\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205287\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205305\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9733\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9733|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?31/36/32325?source=related_link\">",
"      Oxymorphone: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_8_32904="Central craniofacial pain";
var content_f32_8_32904=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Central craniofacial pain",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/8/32904/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/8/32904/contributors\">",
"     Ivan Garza, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/8/32904/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/8/32904/contributors\">",
"     Jerry W Swanson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/8/32904/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/8/32904/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/8/32904/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;By definition, \"central pain\" is neuropathic pain caused by a lesion or dysfunction in the central nervous system. The clinical presentation can be quite variable among patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/1\">",
"     1",
"    </a>",
"    ]. The current International Classification of Headache Disorders contains five distinct entities that are central causes of facial pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Anesthesia dolorosa",
"     </li>",
"     <li>",
"      Central post-stroke pain",
"     </li>",
"     <li>",
"      Facial pain attributed to multiple sclerosis",
"     </li>",
"     <li>",
"      Persistent idiopathic facial pain",
"     </li>",
"     <li>",
"      Burning mouth syndrome",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will discuss central craniofacial pain. Cranial neuralgias are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/10/11431?source=see_link\">",
"     \"Overview of craniofacial pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/23/31090?source=see_link\">",
"     \"Cold stimulus headache\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/48/6917?source=see_link\">",
"     \"Nervus intermedius (geniculate) neuralgia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/55/16243?source=see_link\">",
"     \"Nummular headache\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/49/31509?source=see_link\">",
"     \"Occipital neuralgia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/3/34873?source=see_link\">",
"     \"Trigeminal neuralgia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A lesion at any level of the central nervous system from the spinal trigeminal nucleus or spinal dorsal horn to the cerebral cortex has the potential for causing central craniofacial pain. There may be a higher risk for developing central pain when the spinothalamic and quintothalamic pathways are affected, compared with suprathalamic lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the mechanisms are poorly understood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/3\">",
"     3",
"    </a>",
"    ], two general hypothetic processes have been implicated. In the first one, an \"irritative lesion\" affecting somatosensory pathways may lead to increased activity in otherwise normal nociceptive pathways. In the second one, neurons, remote from the lesion site, become hyperactive and hypersensitive after losing normal synaptic inputs through \"denervation\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/1\">",
"     1",
"    </a>",
"    ]. Either way, the result of the central nervous system lesion is an abnormal, sensitized state of central structures leading to persistent pain in the absence of ongoing tissue injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     GENERAL CHARACTERISTICS OF CENTRAL PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinically, the presentation of central craniofacial pain can vary significantly in severity, character, and location. Pain can be constant or intermittent, and pain intensity can range from mild to excruciating [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/1\">",
"     1",
"    </a>",
"    ]. Characteristic symptoms, alone or combined, include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Muscle pain, felt as cramping, constriction, or crushing",
"     </li>",
"     <li>",
"      Dysesthesias, most commonly with a burning character. Dysesthesias may be poorly localized and may be constant or intermittent in response to a stimulus (pain may be delayed after the stimulus in central pain)",
"     </li>",
"     <li>",
"      Hyperpathia (a heightened response to noxious stimuli)",
"     </li>",
"     <li>",
"      Allodynia (interpretation of nonpainful stimuli as painful)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Shooting/lancinating",
"      </span>",
"      intermittent pain",
"     </li>",
"     <li>",
"      Circulatory-like pain (pins and needles, stings, jabs) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/5\">",
"       5",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Internal and external stimuli, including cold, movement, light touch, and emotional distress, often exacerbate central pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/1\">",
"     1",
"    </a>",
"    ]. Steady and evoked pain (allodynia and hyperpathia) is most commonly encountered in central pain caused by brain lesions, while neuralgic pain due to brain lesions is rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/3,6\">",
"     3,6",
"    </a>",
"    ]. Nevertheless, central pain can be difficult to describe, and most patients experience more than one pain quality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/1\">",
"     1",
"    </a>",
"    ]. Bizarre, vague terms might be utilized by patients attempting to explain what they are feeling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Central pain results from central nervous system lesions. Hence, it should occur in association with neurologic symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    signs such as impaired somatic sensibility. The onset of central pain often coincides with, or shortly follows, the return of transiently lost or impaired sensation related to a lesion affecting somatosensory pathways. However, the onset of the pain may be delayed for years after the insult [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition, central pain can occur even after a brain lesion that left no permanent, clinically-detectable sensory loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of central craniofacial pain is made when clinical evidence supports a disease process in the central nervous system and the pain characteristics are consistent with central pain.",
"   </p>",
"   <p>",
"    The following are suggested general diagnostic criteria for central pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      History of disease in the brain or spinal cord",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Laboratory/radiologic",
"      </span>",
"      support of central nervous system disease",
"     </li>",
"     <li>",
"      Pain starting after the onset of central nervous system disease, with the onset of pain often delayed",
"     </li>",
"     <li>",
"      Pain with a regional distribution, rather than corresponding to individual nerves",
"     </li>",
"     <li>",
"      Pain quality compatible with central pain",
"     </li>",
"     <li>",
"      Sensory abnormality is present",
"     </li>",
"     <li>",
"      Non-sensory symptoms and signs may or may not be present",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL SYNDROMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are five distinct syndromes recognized as central causes of facial pain by the International Classification of Headache Disorders 2nd edition (ICHD-2) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ]. The descriptions and respective diagnostic criteria have been obtained from this classification. However, a significant minority of facial pain cases are unclassifiable using the strict diagnostic criteria of ICHD-2 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/7\">",
"     7",
"    </a>",
"    ]. In one series of 97 consecutive patients referred for facial pain to a tertiary care neurologic center, the proportion who could not be classified was 29 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Anesthesia dolorosa",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anesthesia dolorosa is characterized by persistent, painful anesthesia or hypesthesia in the distribution of the trigeminal nerve or one of its divisions, or of the occipital nerves [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ]. This condition is a perfect example of how difficult central pain can be to describe since the patient has sensory loss, but at the same time, can feel pain. In anesthesia dolorosa, pain is superimposed in an area of the face that either lacks or has impaired sensation.",
"   </p>",
"   <p>",
"    Diagnostic criteria for anesthesia dolorosa include the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Persistent pain and dysesthesia within the area of distribution of one or more divisions of the trigeminal nerve or of the occipital nerves",
"     </li>",
"     <li>",
"      Diminished sensation to pin-prick and sometimes other sensory loss over the affected area",
"     </li>",
"     <li>",
"      Lesion of the relevant nerve or its central connections",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although sometimes related to surgical trauma of the occipital nerves or trigeminal ganglion, anesthesia dolorosa most frequently occurs as a complication of rhizotomy or thermocoagulation done to treat trigeminal neuralgia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ]. Both central and peripheral nervous system lesions can cause this entity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In case series of patients treated for trigeminal neuralgia, anesthesia dolorosa has developed after glycerol rhizotomy in 0 to 1.6 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/9-13\">",
"     9-13",
"    </a>",
"    ], after radiofrequency rhizotomy in 0.8 to 2 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/14,15\">",
"     14,15",
"    </a>",
"    ], and following percutaneous controlled thermocoagulation in 3 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/16\">",
"     16",
"    </a>",
"    ]. Anesthesia dolorosa has not been reported after partial trigeminal rhizotomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/17\">",
"     17",
"    </a>",
"    ], retrolabyrinthine selective posterior root section of the trigeminal nerve [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/18,19\">",
"     18,19",
"    </a>",
"    ], microvascular decompression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/20,21\">",
"     20,21",
"    </a>",
"    ], or trigeminal",
"    <span class=\"nowrap\">",
"     nerve/ganglion",
"    </span>",
"    compression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/22-25\">",
"     22-25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Anesthesia dolorosa can be more intolerable than the pain from trigeminal neuralgia itself [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/26\">",
"     26",
"    </a>",
"    ]. This risk warrants careful decision making when considering surgical treatment for trigeminal neuralgia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/3/34873?source=see_link&amp;anchor=H20#H20\">",
"     \"Trigeminal neuralgia\", section on 'Surgical therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Central post-stroke pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Central post-stroke pain is characterized by unilateral pain and dysesthesia associated with impaired sensation involving part or the whole of the face that is not explicable by a lesion of the trigeminal nerve. It is attributed to a lesion involving the trigeminothalamic (quintothalamic) pathway, thalamus, or thalamocortical projection. Depending on the specific site of the lesion, the trunk",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    limbs may or may not be affected in either the ipsilateral or contralateral side of body [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ]. The disorder may affect 8 to 11 percent of stroke victims [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diagnostic criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ] include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pain and dysesthesia in one-half of the face associated with loss of sensation to pin-prick, temperature,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      touch",
"     </li>",
"     <li>",
"      One or both of the following must be present:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      History of sudden onset suggesting a vascular lesion (stroke)",
"     </li>",
"     <li>",
"      Demonstration of a vascular lesion in an appropriate site by CT or MRI",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pain and dysesthesia must develop within six months after stroke",
"     </li>",
"     <li>",
"      The pain is not explicable by a lesion of the trigeminal nerve",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The pain is usually persistent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ], but can also be paroxysmal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/28\">",
"     28",
"    </a>",
"    ]. In contradistinction to the ICHD-2 diagnostic criteria, its onset may be delayed months or even years after the vascular insult, which can be either ischemic or hemorrhagic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/1\">",
"     1",
"    </a>",
"    ]. The intensity of the pain may vary, may increase by",
"    <span class=\"nowrap\">",
"     physical/emotional",
"    </span>",
"    stress, and may be alleviated by relaxation. The pain can be a great burden in some patients, leading to severe depression, and even suicide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Facial pain attributed to multiple sclerosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Facial pain attributed to multiple sclerosis is described as unilateral or bilateral facial pain, with or without dysesthesia, attributed to a demyelinating lesion of the central connections of the trigeminal nerve [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ], that commonly remits and relapses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ]. Typical trigeminal neuralgia occurs in 1 to 2 percent of patients with multiple sclerosis, about 20 times the prevalence in the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/29\">",
"     29",
"    </a>",
"    ]. Conversely, multiple sclerosis is the cause of trigeminal neuralgia in about 2 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diagnostic criteria include the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pain, with or without dysesthesia, in one or both sides of the face",
"     </li>",
"     <li>",
"      Evidence that the patient has multiple sclerosis",
"     </li>",
"     <li>",
"      Pain and dysesthesia develop in close temporal relation to, and with MRI demonstration of, a demyelinating lesion in the pons or quintothalamic (trigeminothalamic) pathway",
"     </li>",
"     <li>",
"      Other causes have been ruled out",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The pain may be continuous or neuralgiform [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ]. A multiple sclerosis plaque in the pons, at the trigeminal nerve entry zone, can give rise to a clinical scenario indistinguishable from trigeminal neuralgia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/3/34873?source=see_link&amp;anchor=H4#H4\">",
"     \"Trigeminal neuralgia\", section on 'Etiology and pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Persistent idiopathic facial pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent idiopathic facial pain (previously known as atypical face pain) is characterized by persistent facial pain that does not have the characteristics of the cranial neuralgias and is not attributed to another disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diagnostic criteria include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pain in the face, present daily, and persisting for all or most of the day, fulfilling the following two criteria:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Pain is confined at onset to a limited area on one side of the face, and is deep and poorly localized",
"     </li>",
"     <li>",
"      Pain is not associated with sensory loss or other physical signs",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Investigations, including radiographs of face and jaws, do not demonstrate any relevant abnormality",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Even though surgery or injury to the face, teeth, or gums may initiate the symptoms, these persist without a clear local cause. The pain is commonly felt in the nasolabial fold or one side of the chin, but can spread to wider areas of the face and neck. Caution is advised when pain localizes around the ear or temple since invasion of the vagus nerve by lung cancer may refer pain to these regions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Persistent idiopathic facial pain is a diagnosis of exclusion; potential structural lesions, such as craniofacial neoplasms or abscesses, among others, need to be ruled out. Most cases are found in women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because it is essentially a face pain without a clear cause, persistent idiopathic facial pain is sometimes attributed to a psychogenic etiology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/32\">",
"     32",
"    </a>",
"    ]. However, this is not appropriate since there is enough reason to believe that persistent idiopathic facial pain is a central pain syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/30\">",
"     30",
"    </a>",
"    ]. Although depression may be present, there is no evidence to support depression as the etiology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Burning mouth syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burning mouth syndrome is characterized by an intraoral burning sensation for which no medical or dental cause can be found [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ]. Prior to making the diagnosis, it is important to rule out oral mucosal diseases, such as herpes simplex and aphthous stomatitis.",
"   </p>",
"   <p>",
"    Other common conditions associated with mouth pain are psychiatric disorders, xerostomia (from drugs, connective tissue disease, or age), nutritional deficiencies (vitamin B12, iron, folate, zinc, vitamin B6), and allergic contact stomatitis. More unusual causes of mouth pain include geographic tongue, candidiasis, diabetes, denture-related pain, thyroid abnormalities, and menopause [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study suggests that trigeminal small-fiber sensory neuropathy is the cause of so-called idiopathic burning mouth syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/35\">",
"     35",
"    </a>",
"    ]. Other studies identified a significantly higher number of unoccupied D2 dopamine receptors in the putamen associated with painful clinical conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/36\">",
"     36",
"    </a>",
"    ]. In this regard, a report described a patient with burning mouth syndrome whose pain responded to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/19/32055?source=see_link\">",
"     pramipexole",
"    </a>",
"    , a nonergot dopamine agonist with a high selectivity for dopaminergic D2 receptors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treating the underlying cause of mouth pain, if found, usually results in the remission of the symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/30\">",
"     30",
"    </a>",
"    ]. When no underlying cause of symptoms is found, the condition is called \"burning mouth syndrome\".",
"   </p>",
"   <p>",
"    The diagnostic criteria include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pain in the mouth present daily and persisting for most of the day",
"     </li>",
"     <li>",
"      Oral mucosa is of normal appearance",
"     </li>",
"     <li>",
"      Local and systemic diseases have been excluded",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pain may be restricted to the tongue and may be associated with paresthesias, altered taste,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a sensation of having a dry mouth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"     2",
"    </a>",
"    ]. This condition predominantly affects women, and 30 to 50 percent of patients improve spontaneously [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited epidemiologic data are available.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An estimated one in every 100 to 200 patients with stroke will develop central post-stroke facial pain [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In patients with multiple sclerosis, one series of 1672 patients found that the frequency of dysesthetic pain was 18 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/38\">",
"       38",
"      </a>",
"      ]. Another series with 364 patients found that the frequency of central pain was 28 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/39\">",
"       39",
"      </a>",
"      ]. However, it is unclear how many of the patients in these reports had facial pain attributed to multiple sclerosis.",
"     </li>",
"     <li>",
"      In a study of Dutch primary care patients, the incidence of atypical facial pain (persistent idiopathic facial pain) was 39.5 per 100,000 person-years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The frequencies of anesthesia dolorosa and burning mouth syndrome are unknown [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PHARMACOLOGIC TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy for central pain can be challenging. Most central craniofacial treatment options fit into the following categories [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Drugs that reduce central nervous system activity (anticonvulsants, benzodiazepines,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/31/36342?source=see_link\">",
"       baclofen",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Drugs that enhance the reuptake of serotonin and noradrenaline (antidepressants).",
"     </li>",
"     <li>",
"      Drugs that influence adrenoceptors (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?18/53/19289?source=see_link\">",
"       clonidine",
"      </a>",
"      ) and direct opiate receptor agonists. Of note, these agents are typically prescribed by a pain specialist. We do not commonly use them.",
"     </li>",
"     <li>",
"      Peripheral and central electrical stimulation (see",
"      <a class=\"local\" href=\"#H23\">",
"       'Surgical therapy'",
"      </a>",
"      below).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Limited scientific evidence is available regarding pharmacotherapy for most types of central pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/6\">",
"     6",
"    </a>",
"    ]. Except for a few drugs, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/30/27112?source=see_link\">",
"     amitriptyline",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    , treatment is based on anecdotal observations and consensus opinions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/1\">",
"     1",
"    </a>",
"    ]. Furthermore, it is unknown whether a treatment that is effective in one central pain syndrome can be beneficial in another central pain condition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A treatment algorithm for neuropathic pain has been proposed based upon a systematic review of randomized clinical trials in various central and peripheral neuropathic pain conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/41\">",
"     41",
"    </a>",
"    ]. The following recommendations were made for central neuropathic pain:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tricyclic antidepressants are first-line agents.",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"mobipreview.htm?19/19/19768?source=see_link\">",
"        Gabapentin",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"mobipreview.htm?16/31/16887?source=see_link\">",
"        pregabalin",
"       </a>",
"      </span>",
"      are second choices. However, these agents are first choices in the elderly or when tricyclics are contraindicated.",
"     </li>",
"     <li>",
"      Opioids are third-line agents.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When medications of choice fail, a trial-and-error approach can be attempted with other drugs that have been used for neuropathic pain, including but not limited to,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/45/26328?source=see_link\">",
"     clonazepam",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/11/25785?source=see_link\">",
"     valproate",
"    </a>",
"    , phenothiazines, serotonin-norepinephrine reuptake inhibitors,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/9/10389?source=see_link\">",
"     mexiletine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/31/36342?source=see_link\">",
"     baclofen",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In studies evaluating treatment of specific clinical syndromes recognized as central causes of facial pain, the following observations have been made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For anesthesia dolorosa, there is a case report of improvement using",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/19/19768?source=see_link\">",
"       gabapentin",
"      </a>",
"      1200 mg daily [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      For central post-stroke pain,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/30/27112?source=see_link\">",
"       amitriptyline",
"      </a>",
"      (titrated to 75 mg daily) and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?6/28/6602?source=see_link\">",
"       lamotrigine",
"      </a>",
"      (titrated to 200 mg daily) are the only medications shown to be effective in small randomized controlled trials, but",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/19/19768?source=see_link\">",
"       gabapentin",
"      </a>",
"      (up to 2400 mg daily) has shown promising results [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/28,43,44\">",
"       28,43,44",
"      </a>",
"      ]. Still, amitriptyline is considered first-line treatment for central post-stroke pain.",
"     </li>",
"     <li>",
"      For paroxysmal or neuralgic pain associated with multiple sclerosis,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      is the drug of choice [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/1,45\">",
"       1,45",
"      </a>",
"      ]. The evidence supporting this is consensus opinion and clinical observation only.",
"     </li>",
"     <li>",
"      For persistent idiopathic facial pain, tricyclic antidepressants are the preferred treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/46\">",
"       46",
"      </a>",
"      ]. In one case report,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/27/5561?source=see_link\">",
"       topiramate",
"      </a>",
"      (titrated to 125 mg two times a day) was beneficial [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      For burning mouth syndrome, tricyclic antidepressants,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?25/45/26328?source=see_link\">",
"       clonazepam",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/19/19768?source=see_link\">",
"       gabapentin",
"      </a>",
"      may be beneficial, although supporting evidence is scant [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/30,33,48\">",
"       30,33,48",
"      </a>",
"      ]. A systematic review of nine clinical trials identified three interventions that demonstrated a reduction in symptoms compared with placebo [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/48\">",
"       48",
"      </a>",
"      ]. These were alpha-lipoic acid (three trials), clonazepam (one trial), and cognitive behavioral therapy (one trial). Only two of the nine trials reported using blind outcome assessment. As indicated above, one case report described beneficial effects of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/19/32055?source=see_link\">",
"       pramipexole",
"      </a>",
"      &nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Choice of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    as initial therapy for treatment of neuralgic facial pain attributed to multiple sclerosis.",
"   </p>",
"   <p>",
"    For treatment of other types of central craniofacial pain (ie, anesthesia dolorosa, central post-stroke pain, persistent idiopathic facial pain, and burning mouth syndrome), we suggest tricyclic antidepressants as initial pharmacologic therapy.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/30/27112?source=see_link\">",
"     Amitriptyline",
"    </a>",
"    is the most effective tricyclic for central pain. When tricyclic medications are contraindicated or poorly tolerated,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/31/16887?source=see_link\">",
"     pregabalin",
"    </a>",
"    are preferred alternative choices. For patients with central post-stroke pain,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    is another alternative. For patients with burning mouth syndrome, alternatives include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/45/26328?source=see_link\">",
"     clonazepam",
"    </a>",
"    and alpha-lipoic acid.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Doses and side effects",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Carbamazepine",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with neuralgic facial pain attributed to multiple sclerosis,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    may be started at 100 to 200 mg daily; the dose can be increased slowly over several weeks as needed for pain relief to a maximum total dose of 1200 mg per day.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     Carbamazepine",
"    </a>",
"    is associated with rare but serious side effects, including agranulocytosis and aplastic anemia. The Stevens-Johnson syndrome and toxic epidermal necrolysis are additional rare complications, particularly during the first eight weeks of therapy, and are significantly more common (estimated incidence of 5 percent) among patients with the HLA-B*1502 allele [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/49\">",
"     49",
"    </a>",
"    ]. This allele occurs almost exclusively in patients of Asian ancestry, including South Asian Indians. Screening for this allele is recommended in patients of these ethnic groups prior to starting carbamazepine. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=see_link&amp;anchor=H20#H20\">",
"     \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\", section on 'Genetic factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Amitriptyline",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/30/27112?source=see_link\">",
"     Amitriptyline",
"    </a>",
"    can be started at 10 to 25 mg nightly, and titrated up in 10 to 25 mg steps every one to three weeks as tolerated and as needed for pain relief, or until a maximum dose of 100 to 125 mg nightly is reached. Amitriptyline and most other tricyclics are sedating. Additional side effects of tricyclics include dry mouth, constipation, tachycardia, palpitations, orthostatic hypotension, weight gain, blurred vision, and urinary retention. Confusion can occur, particularly in the elderly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Gabapentin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/19/19768?source=see_link\">",
"     Gabapentin",
"    </a>",
"    can be started at 300 mg daily and titrated up as needed for pain relief. Adequate relief is typically achieved with gabapentin doses ranging from 900 to 2400 mg daily, given in three divided doses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/50\">",
"     50",
"    </a>",
"    ]. Doses as high as 3600 mg daily are tolerated by most patients. The most common adverse effects include somnolence, diarrhea, mood swings, ataxia, fatigue, nausea, and dizziness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Pregabalin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/31/16887?source=see_link\">",
"     Pregabalin",
"    </a>",
"    is started at 50 mg three times a day (total 150",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    and is then slowly increased to 100 mg three times a day (total 300",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    over a week or more. When stopping the drug, it should be tapered over a week, as withdrawal symptoms may occur. Common side effects of pregabalin are dizziness, somnolence, dry mouth, peripheral edema, and weight gain. Pregabalin can also cause sedation and confusion. It is designated as a schedule V controlled substance in the United States because it has been reported to cause euphoria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Lamotrigine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/28/6602?source=see_link\">",
"     Lamotrigine",
"    </a>",
"    is started at 25 mg daily for the first two weeks of therapy. The dose can then be increased to 50 mg daily for weeks three and four, 100 mg daily for week five, and 200 mg daily beginning week six. Rash is the most common side effect associated with lamotrigine treatment and requires discontinuation of the drug, since a hypersensitivity reaction may result and lead to life-threatening complications such as Stevens-Johnson syndrome and toxic epidermal necrolysis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Clonazepam",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/45/26328?source=see_link\">",
"     Clonazepam",
"    </a>",
"    is started at 0.25 mg daily and increased by 0.25 mg weekly as needed. Doses of up to 20 mg daily have been used in epilepsy, but 3 to 6 mg daily (given in three divided doses) is more common when treating burning mouth syndrome. The most common side effects of clonazepam are drowsiness, dizziness, fatigue, and sedation. As with other benzodiazepines, clonazepam may produce physical and psychological dependence; abrupt discontinuation should be avoided.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Alpha-lipoic acid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alpha-lipoic acid can be used at doses ranging from 20 to 1800 mg daily. Most often it is given in the range of 200 to 600 mg daily in one or two divided doses. Doses higher than 600 mg a day are more likely to lead to adverse events (nausea, vomiting, vertigo).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Topiramate",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/27/5561?source=see_link\">",
"     Topiramate",
"    </a>",
"    is started at 25 mg daily. The dose can be increased to as high as 400 mg daily in two divided doses over eight weeks; the optimal dose for treating persistent idiopathic facial pain is unknown. Common side effects of topiramate include anorexia and weight loss. Impaired cognition occurs in a minority of patients taking topiramate, and is reversible with drug discontinuation. Patients taking topiramate for prolonged periods may develop kidney stones due to the inhibition of carbonic anhydrase.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SURGICAL THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical therapy is reserved for cases that have failed noninvasive measures, have no contraindications, and are associated with significant disability to warrant such a procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/6\">",
"     6",
"    </a>",
"    ]. Transcutaneous electrical nerve stimulation is recommended as an initial option by some authors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/1\">",
"     1",
"    </a>",
"    ]. Chronic electrical stimulation of the gasserian ganglion provided at least 50 percent relief in five of seven patients with central post-stroke facial pain in one series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Encouraging results have been obtained since the 1990s with chronic motor cortex stimulation. In a literature review that identified 38 patients with neuropathic facial pain who were treated with motor cortex stimulation, &gt;50 percent pain relief was achieved in 29 patients (76 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/52\">",
"     52",
"    </a>",
"    ]. However, this cohort included both peripheral and central neuropathic pain syndromes. The relief after motor cortex stimulation may subside with time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Deep brain stimulation and destructive lesions, such as medial thalamotomy, are last resort procedures, only considered after other alternatives have failed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32904/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A lesion at any level of the central nervous system, from the spinal trigeminal nucleus or spinal dorsal horn to the cerebral cortex, has the potential for causing central craniofacial pain. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Anatomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Five distinct syndromes are recognized as central causes of facial pain. However, a significant minority of facial pain cases are unclassifiable using current diagnostic criteria. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical syndromes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Anesthesia dolorosa is characterized by persistent, painful anesthesia or hypesthesia in the distribution of the trigeminal nerve or one of its divisions, or of the occipital nerves. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Anesthesia dolorosa'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Central post-stroke pain is characterized by unilateral pain and dysesthesia associated with impaired sensation involving part or the whole of the face, not explicable by a lesion of the trigeminal nerve. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Central post-stroke pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Facial pain attributed to multiple sclerosis is characterized by unilateral or bilateral facial pain, with or without dysesthesia, attributed to a demyelinating lesion of the central connections of the trigeminal nerve. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Facial pain attributed to multiple sclerosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Persistent idiopathic facial pain (or atypical face pain) is characterized by persistent facial pain that does not have the characteristics of the cranial neuralgias and is not attributed to another disorder. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Persistent idiopathic facial pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Burning mouth syndrome is characterized by an intraoral burning sensation for which no medical or dental cause can be found. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Burning mouth syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Limited scientific evidence is available regarding pharmacotherapy for most types of central pain. Except for a few drugs, treatment is based on anecdotal observations and consensus opinions. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Pharmacologic treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with neuralgic facial pain attributed to multiple sclerosis, we suggest treatment with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Pharmacologic treatment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Carbamazepine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with anesthesia dolorosa, central post-stroke pain, persistent idiopathic facial pain, or burning mouth syndrome, we suggest initial therapy with tricyclic antidepressants (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/30/27112?source=see_link\">",
"       Amitriptyline",
"      </a>",
"      is the preferred tricyclic. For patients intolerant of or unresponsive to tricyclics,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/19/19768?source=see_link\">",
"       gabapentin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/31/16887?source=see_link\">",
"       pregabalin",
"      </a>",
"      are alternatives. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Pharmacologic treatment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Amitriptyline'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Gabapentin'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'Pregabalin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with central post-stroke pain,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?6/28/6602?source=see_link\">",
"       lamotrigine",
"      </a>",
"      is another alternative. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Pharmacologic treatment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Lamotrigine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with persistent idiopathic facial pain,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/27/5561?source=see_link\">",
"       topiramate",
"      </a>",
"      is an alternative. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Pharmacologic treatment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'Topiramate'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with burning mouth syndrome, alternatives include",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?25/45/26328?source=see_link\">",
"       clonazepam",
"      </a>",
"      and alpha-lipoic acid. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Pharmacologic treatment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H20\">",
"       'Clonazepam'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21\">",
"       'Alpha-lipoic acid'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical therapy is reserved for patients with central craniofacial pain who have significant disability, have failed noninvasive measures, and have no contraindications. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Surgical therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Boivie, J, Casey, KL. Central pain in the face and head. In: The Headaches, Olesen, J (ed), Lippincott Williams and Wilkins, Philadelphia, PA USA 2006. p.1063.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/2\">",
"      Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 Suppl 1:9.",
"     </a>",
"    </li>",
"    <li>",
"     Tasker, RR. Central pain states. In: Principles and practice of pain medicine, Warfield, CA, Bajwa, ZH (Eds), McGraw-Hill, USA 2004. p.394.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/4\">",
"      Rowbotham MC. Mechanisms of neuropathic pain and their implications for the design of clinical trials. Neurology 2005; 65:S66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/5\">",
"      Nicholson BD. Evaluation and treatment of central pain syndromes. Neurology 2004; 62:S30.",
"     </a>",
"    </li>",
"    <li>",
"     Tasker, RR, Watson, CPN. The treatment of central pain. In: Neurological therapeutics: Principles and practice, Noseworthy JH (Ed), Martin Dunitz, London, New York 2003. p.214.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/7\">",
"      Zebenholzer K, W&ouml;ber C, Vigl M, et al. Facial pain and the second edition of the International Classification of Headache Disorders. Headache 2006; 46:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/8\">",
"      Zebenholzer K, W&ouml;ber C, Vigl M, et al. Facial pain in a neurological tertiary care centre--evaluation of the International Classification of Headache Disorders. Cephalalgia 2005; 25:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/9\">",
"      Blomstedt PC, Bergenheim AT. Technical difficulties and perioperative complications of retrogasserian glycerol rhizotomy for trigeminal neuralgia. Stereotact Funct Neurosurg 2002; 79:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/10\">",
"      Ischia S, Luzzani A, Polati E. Retrogasserian glycerol injection: a retrospective study of 112 patients. Clin J Pain 1990; 6:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/11\">",
"      Fujimaki T, Fukushima T, Miyazaki S. Percutaneous retrogasserian glycerol injection in the management of trigeminal neuralgia: long-term follow-up results. J Neurosurg 1990; 73:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/12\">",
"      Sahni KS, Pieper DR, Anderson R, Baldwin NG. Relation of hypesthesia to the outcome of glycerol rhizolysis for trigeminal neuralgia. J Neurosurg 1990; 72:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/13\">",
"      Young RF. Glycerol rhizolysis for treatment of trigeminal neuralgia. J Neurosurg 1988; 69:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/14\">",
"      Mathews ES, Scrivani SJ. Percutaneous stereotactic radiofrequency thermal rhizotomy for the treatment of trigeminal neuralgia. Mt Sinai J Med 2000; 67:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/15\">",
"      Kanpolat Y, Savas A, Bekar A, Berk C. Percutaneous controlled radiofrequency trigeminal rhizotomy for the treatment of idiopathic trigeminal neuralgia: 25-year experience with 1,600 patients. Neurosurgery 2001; 48:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/16\">",
"      Ischia S, Luzzani A, Polati E, Ischia A. Percutaneous controlled thermocoagulation in the treatment of trigeminal neuralgia. Clin J Pain 1990; 6:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/17\">",
"      Gelber BR, Gogela LJ, Pierson EW. Posterior fossa partial trigeminal rhizotomy: an alternative to microvascular decompression. Nebr Med J 1989; 74:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/18\">",
"      Pulec JL, Hitselberger WE. Trigeminal neuralgia: retrolabyrinthine selective posterior root section. Laryngoscope 1977; 87:1861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/19\">",
"      Pulec JL. Retrolabyrinthine selective posterior root section of the trigeminal nerve for the treatment of trigeminal neuralgia. Ear Nose Throat J 1996; 75:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/20\">",
"      Chang JW, Chang JH, Park YG, Chung SS. Microvascular decompression in trigeminal neuralgia: a correlation of three-dimensional time-of-flight magnetic resonance angiography and surgical findings. Stereotact Funct Neurosurg 2000; 74:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/21\">",
"      Klun B. Microvascular decompression and partial sensory rhizotomy in the treatment of trigeminal neuralgia: personal experience with 220 patients. Neurosurgery 1992; 30:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/22\">",
"      Brown JA, McDaniel MD, Weaver MT. Percutaneous trigeminal nerve compression for treatment of trigeminal neuralgia: results in 50 patients. Neurosurgery 1993; 32:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/23\">",
"      Skirving DJ, Dan NG. A 20-year review of percutaneous balloon compression of the trigeminal ganglion. J Neurosurg 2001; 94:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/24\">",
"      Lobato RD, Rivas JJ, Sarabia R, Lamas E. Percutaneous microcompression of the gasserian ganglion for trigeminal neuralgia. J Neurosurg 1990; 72:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/25\">",
"      Brown JA, Preul MC. Percutaneous trigeminal ganglion compression for trigeminal neuralgia. Experience in 22 patients and review of the literature. J Neurosurg 1989; 70:900.",
"     </a>",
"    </li>",
"    <li>",
"     Heros, RC, Heros, DA, Schumacher, JM, et al. Principles of neurosurgery. In: Neurology in clinical practice, Bradley, WG, Daroff, RB, Fenichel, GM (Eds), Butterworth Heinemann, Philadelphia 2004. p.963.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/27\">",
"      Sadosky A, McDermott AM, Brandenburg NA, Strauss M. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract 2008; 8:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/28\">",
"      Frese A, Husstedt IW, Ringelstein EB, Evers S. Pharmacologic treatment of central post-stroke pain. Clin J Pain 2006; 22:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/29\">",
"      O'Connor AB, Schwid SR, Herrmann DN, et al. Pain associated with multiple sclerosis: systematic review and proposed classification. Pain 2008; 137:96.",
"     </a>",
"    </li>",
"    <li>",
"     Cranial neuralgias and central causes of facial pain. In: Mechanism and management of headache, Lance, JW, Goadsby, PJ (Eds), Elsevier Butterworth Heinemann, Philadelphia, PA 2005. p.333.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/31\">",
"      Manzoni GC, Torelli P. Epidemiology of typical and atypical craniofacial neuralgias. Neurol Sci 2005; 26 Suppl 2:s65.",
"     </a>",
"    </li>",
"    <li>",
"     Boes, CJ, Copobianco, DJ, Cutrer, FM, et al. Headache and other craniofacial pain. In: Neurology in clinical practice, Bradley, WG, Daroff, RB, Fenichel, GM, et al (Eds), Butterworth Heinemann, Philadelphia, PA 2004. p.2055.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/33\">",
"      Evans RW, Drage LA. Burning mouth syndrome. Headache 2005; 45:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/34\">",
"      Maltsman-Tseikhin A, Moricca P, Niv D. Burning mouth syndrome: will better understanding yield better management? Pain Pract 2007; 7:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/35\">",
"      Lauria G, Majorana A, Borgna M, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005; 115:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/36\">",
"      Wood PB. Role of central dopamine in pain and analgesia. Expert Rev Neurother 2008; 8:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/37\">",
"      Stuginski-Barbosa J, Rodrigues GG, Bigal ME, Speciali JG. Burning mouth syndrome responsive to pramipexol. J Headache Pain 2008; 9:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/38\">",
"      Solaro C, Brichetto G, Amato MP, et al. The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology 2004; 63:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/39\">",
"      Osterberg A, Boivie J, Thuomas KA. Central pain in multiple sclerosis--prevalence and clinical characteristics. Eur J Pain 2005; 9:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/40\">",
"      Dieleman JP, Kerklaan J, Huygen FJ, et al. Incidence rates and treatment of neuropathic pain conditions in the general population. Pain 2008; 137:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/41\">",
"      Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005; 118:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/42\">",
"      Rozen TD. Relief of anesthesia dolorosa with gabapentin. Headache 1999; 39:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/43\">",
"      Leijon G, Boivie J. Central post-stroke pain--a controlled trial of amitriptyline and carbamazepine. Pain 1989; 36:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/44\">",
"      Vestergaard K, Andersen G, Gottrup H, et al. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology 2001; 56:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/45\">",
"      Crayton H, Heyman RA, Rossman HS. A multimodal approach to managing the symptoms of multiple sclerosis. Neurology 2004; 63:S12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/46\">",
"      Agostoni E, Frigerio R, Santoro P. Atypical facial pain: clinical considerations and differential diagnosis. Neurol Sci 2005; 26 Suppl 2:s71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/47\">",
"      Volcy M, Rapoport AM, Tepper SJ, et al. Persistent idiopathic facial pain responsive to topiramate. Cephalalgia 2006; 26:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/48\">",
"      Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev 2005; :CD002779.",
"     </a>",
"    </li>",
"    <li>",
"     Information on carbamazepine (marketed as Carbatrol, Equetro, Tegretol, and generics) with FDA Alerts. www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107834.htm (Accessed on January 05, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/50\">",
"      Backonja M, Glanzman RL. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther 2003; 25:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/51\">",
"      Taub E, Munz M, Tasker RR. Chronic electrical stimulation of the gasserian ganglion for the relief of pain in a series of 34 patients. J Neurosurg 1997; 86:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32904/abstract/52\">",
"      Brown JA, Pilitsis JG. Motor cortex stimulation for central and neuropathic facial pain: a prospective study of 10 patients and observations of enhanced sensory and motor function during stimulation. Neurosurgery 2005; 56:290.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3324 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-61.234.146.186-DBEF2E8A07-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_8_32904=[""].join("\n");
var outline_f32_8_32904=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      GENERAL CHARACTERISTICS OF CENTRAL PAIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL SYNDROMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Anesthesia dolorosa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Central post-stroke pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Facial pain attributed to multiple sclerosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Persistent idiopathic facial pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Burning mouth syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PHARMACOLOGIC TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Choice of therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Doses and side effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Carbamazepine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Amitriptyline",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Gabapentin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Pregabalin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Lamotrigine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Clonazepam",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Alpha-lipoic acid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Topiramate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SURGICAL THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/23/31090?source=related_link\">",
"      Cold stimulus headache",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/48/6917?source=related_link\">",
"      Nervus intermedius (geniculate) neuralgia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/55/16243?source=related_link\">",
"      Nummular headache",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/49/31509?source=related_link\">",
"      Occipital neuralgia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/10/11431?source=related_link\">",
"      Overview of craniofacial pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=related_link\">",
"      Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/3/34873?source=related_link\">",
"      Trigeminal neuralgia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_8_32905="Overview of acute wrist injuries in children and adolescents";
var content_f32_8_32905=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of acute wrist injuries in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/8/32905/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/8/32905/contributors\">",
"     D Scott Upton, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/8/32905/contributors\">",
"     Joseph Chorley, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/8/32905/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/8/32905/contributors\">",
"     Albert C Hergenroeder, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/8/32905/contributors\">",
"     Richard G Bachur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/8/32905/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/8/32905/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/8/32905/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injuries to the wrist are common in children, adolescents, and young adults. A thorough understanding of the anatomy of the growing wrist, common wrist injuries, and other causes of wrist pain are essential to accurate diagnosis and appropriate treatment.",
"   </p>",
"   <p>",
"    Causes of acute wrist injuries in children and adolescents will be presented here (",
"    <a class=\"graphic graphic_table graphicRef57608 \" href=\"mobipreview.htm?26/8/26765\">",
"     table 1",
"    </a>",
"    ). Causes of chronic wrist pain, wrist anatomy, and the evaluation of wrist pain in children and adolescents are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/60/38855?source=see_link\">",
"     \"Causes of chronic wrist pain in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/43/32440?source=see_link\">",
"     \"Evaluation of wrist pain and injury in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     FRACTURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fractures are the most common sports-related wrist injury in skeletally immature children and adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/1\">",
"     1",
"    </a>",
"    ]. In such patients, the growing bones are more susceptible to stress than are the surrounding ligaments and joint capsules [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/2-4\">",
"     2-4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Distal radius",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fractures of the distal radius are the most common fracture in children and adolescents, accounting for 35 to 47 percent of wrist fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/5\">",
"     5",
"    </a>",
"    ]. Distal radius fractures occur most frequently during early adolescence; children with increased body mass and decreased bone mineral density are at increased risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. The mechanism of injury is usually a fall on a hyperextended wrist. Distal radius fractures may occur in all sports activities, but are most common in soccer, skiing, dancing, rugby, ice sports, football, and snow boarders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/8-11\">",
"     8-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fractures of the distal radius usually involve the metaphysis. Although physeal (growth plate) injuries are relatively rare, they must be considered carefully because they can result in premature growth arrest. Shortening of the radius can lead to ulnar impaction and triangular fibrocartilage complex (TFCC) tears. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/60/38855?source=see_link&amp;anchor=H14#H14\">",
"     \"Causes of chronic wrist pain in children and adolescents\", section on 'Ulnar impaction'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H21\">",
"     'TFCC injuries'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Clinical findings of distal radius fractures include point tenderness, swelling, ecchymosis, and decreased grip strength [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Associated injuries may include distal radioulnar joint (DRUJ) injuries and TFCC tears. Fractures of the radial shaft with associated dislocation of the DRUJ are known as Galeazzi fractures. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'DRUJ and TFCC injuries'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The diagnosis of a distal radius fracture is confirmed by plain radiographs with the exception of children with nondisplaced Salter-Harris I injuries. Radiographic assessment, classification, and physical examination of these injuries are discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42120?source=see_link&amp;anchor=H730609#H730609\">",
"     \"Diagnosis and assessment of distal forearm fractures in children\", section on 'Radiographic assessment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42120?source=see_link&amp;anchor=H2133715#H2133715\">",
"     \"Diagnosis and assessment of distal forearm fractures in children\", section on 'Physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Metaphyseal",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two most common types of distal radial metaphyseal fractures are torus fractures and greenstick fractures. Torus fractures (also known as buckle fractures) are caused by compressive forces that lead to buckling or plastic deformation of a single cortex (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71495 \" href=\"mobipreview.htm?23/32/24079\">",
"     image 1",
"    </a>",
"    ). Greenstick fractures are incomplete fractures in which one cortex breaks completely while the cortex on the opposite side undergoes plastic deformation; associated angulation or rotation are common (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59653 \" href=\"mobipreview.htm?28/41/29343\">",
"     image 2",
"    </a>",
"    ). Recognition and treatment of these fractures are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42120?source=see_link&amp;anchor=H730609#H730609\">",
"     \"Diagnosis and assessment of distal forearm fractures in children\", section on 'Radiographic assessment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/14/14569?source=see_link&amp;anchor=H23#H23\">",
"     \"Initial management of distal forearm fractures in children\", section on 'Definitive care'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Physeal fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Distal radial physeal injuries must be carefully considered in children with wrist trauma. The physis (growth plate) is a relatively weak area of bone and is susceptible to injury, particularly during the adolescent growth spurt [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/1\">",
"     1",
"    </a>",
"    ]. Physeal fractures are described using the Salter-Harris classification system (",
"    <a class=\"graphic graphic_figure graphicRef54582 \" href=\"mobipreview.htm?20/55/21361\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42120?source=see_link&amp;anchor=H730724#H730724\">",
"     \"Diagnosis and assessment of distal forearm fractures in children\", section on 'Physeal fractures'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/40/20104?source=see_link\">",
"     \"General principles of fracture management: Fracture patterns and description in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with a nondisplaced Salter I physeal fracture of the distal radius or ulna (",
"    <a class=\"graphic graphic_figure graphicRef54582 \" href=\"mobipreview.htm?20/55/21361\">",
"     figure 1",
"    </a>",
"    ) usually have normal plain radiographs at initial presentation. However, bony tenderness is present over the physis in these patients and helps to differentiate this injury from a bruise or ligamentous strain or sprain. Other radiographic findings that may be present soon after injury include a volar fat pad on the lateral view and epiphyseal widening on stress views. However, stress views are painful for the patient and usually unnecessary. Plain radiographs obtained at least seven days after injury will show healing bone in children with nondisplaced Salter I fractures and also provides a definitive diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42120?source=see_link&amp;anchor=H732244#H732244\">",
"     \"Diagnosis and assessment of distal forearm fractures in children\", section on 'Nondisplaced Salter I fracture'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The main concern with physeal fractures is premature closure and growth arrest at the site of injury. The risk of this complication increases with the severity of the fracture. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/14/14569?source=see_link&amp;anchor=H43#H43\">",
"     \"Initial management of distal forearm fractures in children\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Management of distal radial physeal fractures is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/14/14569?source=see_link&amp;anchor=H24#H24\">",
"     \"Initial management of distal forearm fractures in children\", section on 'Physeal fracture'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Distal ulna fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fractures of the distal ulna include distal styloid fractures, fractures at the styloid base, and distal ulna physeal fractures. These fractures are typically associated with distal radial fractures. Complete fractures through the base of the ulnar styloid are uncommon but may be associated with triangular fibrocartilage complex (TFCC) instability since the TFCC attaches at the ulnar styloid (",
"    <a class=\"graphic graphic_figure graphicRef63443 \" href=\"mobipreview.htm?15/39/15986\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef57244 \" href=\"mobipreview.htm?8/0/8194\">",
"     image 3",
"    </a>",
"    ). A distal ulna physeal fracture in association with a radial shaft fracture is a pediatric variation of the Galeazzi fracture pattern and often requires operative stabilization. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42120?source=see_link&amp;anchor=H730752#H730752\">",
"     \"Diagnosis and assessment of distal forearm fractures in children\", section on 'Ulnar styloid fractures'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42120?source=see_link&amp;anchor=H730759#H730759\">",
"     \"Diagnosis and assessment of distal forearm fractures in children\", section on 'Galeazzi fractures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Management of ulnar styloid fractures is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/14/14569?source=see_link&amp;anchor=H2140102#H2140102\">",
"     \"Initial management of distal forearm fractures in children\", section on 'Ulnar styloid fracture'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Carpal fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carpal fractures comprise approximately 6 percent of all fractures in athletes but are probably underdiagnosed. Failure to recognize carpal fractures can result in long-term functional deficits and major complications. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/49/4886?source=see_link\">",
"     \"Overview of carpal fractures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Scaphoid fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Scaphoid (navicular) fractures are the most common carpal fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Scaphoid fractures typically occur in individuals aged 15 to 30 years; they are particularly common among collegiate football players [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/4,16,17\">",
"     4,16,17",
"    </a>",
"    ]. Scaphoid fractures are rare in children younger than 10 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/13,18\">",
"     13,18",
"    </a>",
"    ]. Injury patterns in children are similar to adults. Although 90 percent of pediatric scaphoid fractures will heal with immobilization, three months or more may be needed. Almost one-third of pediatric patients will initially present with chronic non-unions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The patient typically complains of pain along the radial aspect of the wrist after falling on an outstretched hand. The pain may be less severe than the patient or patient's parents expect from an acute fracture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Characteristic examination findings include tenderness of the anatomic snuff box, decreased range of motion in flexion and extension, pain with radial deviation or extension of the wrist, and a positive scaphoid compression test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21\">",
"     21",
"    </a>",
"    ]. The scaphoid compression test is performed by holding the thumb and gradually pushing in toward the scaphoid along the longitudinal axis of the thumb metacarpal; elicitation of pain over the palmar scaphoid tubercle constitutes a positive test. Complications of scaphoid fractures include carpal instability, osteonecrosis, and nonunion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/43/32440?source=see_link&amp;anchor=H20#H20\">",
"     \"Evaluation of wrist pain and injury in children and adolescents\", section on 'Scaphoid fractures'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/51/1848?source=see_link\">",
"     \"Scaphoid fractures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On plain radiographs, scaphoid fractures are best visualized with the anteroposterior (AP) scaphoid view with 30&ordm; of ulnar deviation. They may not be evident on the standard wrist series, even if the ulnar deviation view is included [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/51/1848?source=see_link&amp;anchor=H7#H7\">",
"     \"Scaphoid fractures\", section on 'Management of suspected fracture with negative plain radiographs'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If scaphoid fracture is suspected on the basis of clinical findings and the radiographs are normal, the wrist should be immobilized in a thumb spica splint (",
"    <a class=\"graphic graphic_figure graphicRef79534 \" href=\"mobipreview.htm?26/19/26943\">",
"     figure 3",
"    </a>",
"    ) pending confirmation or exclusion of the diagnosis at follow-up examination (with radiographs) 10 to 14 days after the injury (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75655 \" href=\"mobipreview.htm?12/45/13010\">",
"     image 4",
"    </a>",
"    ). If the diagnosis must be confirmed or excluded in a shorter time-frame (eg, in an elite athlete), bone scan or MRI may be performed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/51/1848?source=see_link&amp;anchor=H7#H7\">",
"     \"Scaphoid fractures\", section on 'Management of suspected fracture with negative plain radiographs'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of scaphoid fractures is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/51/1848?source=see_link&amp;anchor=H9#H9\">",
"     \"Scaphoid fractures\", section on 'Indications for surgical referral'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/51/1848?source=see_link&amp;anchor=H11#H11\">",
"     \"Scaphoid fractures\", section on 'Initial treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Triquetral fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The usual mechanism of injury for triquetral fractures involves falling on an extended wrist in ulnar deviation, which causes impingement of the hamate or the ulnar styloid on the dorsal edge of the triquetrum. However, triquetral fractures may also occur following flexion injuries in which fragments of the triquetrum may be avulsed by the strong dorsal ligaments. Triquetral fractures are associated with carpal instability.",
"   </p>",
"   <p>",
"    Patients typically present with a history of injury and pain on the ulnar aspect of the wrist. Examination findings include pain and point tenderness either dorsally directly over the triquetrum, or on the ulnar border of the wrist, distal to the ulnar styloid (",
"    <a class=\"graphic graphic_figure graphicRef78359 \" href=\"mobipreview.htm?26/34/27172\">",
"     figure 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/16\">",
"     16",
"    </a>",
"    ]. The triquetrum is most easily palpated with the wrist in radial deviation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/55/36723?source=see_link\">",
"     \"Triquetral fractures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most triquetral fractures can be demonstrated on plain radiographs, particularly a partially pronated AP view (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59010 \" href=\"mobipreview.htm?5/53/5983\">",
"     image 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef81364 \" href=\"mobipreview.htm?43/6/44142\">",
"     image 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67772 \" href=\"mobipreview.htm?30/31/31230\">",
"     image 7",
"    </a>",
"    ). Lateral views must be examined closely for any malalignment or instability pattern. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/55/36723?source=see_link&amp;anchor=H5#H5\">",
"     \"Triquetral fractures\", section on 'Radiographic findings'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Management of triquetral fractures involves immobilization with a volar splint which varies in duration based upon the type of fracture. For the athlete, a playing splint can be fashioned to allow for early return to play. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/55/36723?source=see_link&amp;anchor=H7#H7\">",
"     \"Triquetral fractures\", section on 'Initial treatment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/55/36723?source=see_link&amp;anchor=H9#H9\">",
"     \"Triquetral fractures\", section on 'Recommendations for return to sport or work'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Mild ulnar-sided wrist discomfort may continue for several months. However, the clinician should be alert to the possibility of other undiagnosed pathology, such as a lunotriquetral ligament tear, pisiform fracture, or injury to the triangular fibrocartilage complex. The presence of such an injury is suggested by marked or persistent swelling, limited wrist motion, or continued pain at the ulnar aspect of the wrist despite demonstrated radiographic healing. In such instances, a MR arthrogram may be used to assess ligamentous disruption and evaluation by a hand surgeon is prudent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/55/36723?source=see_link&amp;anchor=H6#H6\">",
"     \"Triquetral fractures\", section on 'Indications for surgical referral'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Hamate fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fractures of the hook of the hamate, rare in the general population, are more common in skeletally mature players of racquet, stick, or club sports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/22\">",
"     22",
"    </a>",
"    ]. The swinging action required in these sports transfers force directly to the hook of the hamate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/17,23\">",
"     17,23",
"    </a>",
"    ]. The wrist nearest the handle is most susceptible (eg, the nondominant hand in baseball or golf, the dominant hand in racquet sports) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/24\">",
"     24",
"    </a>",
"    ]. Fractures of the body of the hamate typically result from significant crush injuries (eg, a fall while holding an object in which the object lands between the ground and the ulnar side of the palm) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients with fractures of the hook of the hamate present late, complaining of chronic pain, rather than acutely at the time of injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/13\">",
"     13",
"    </a>",
"    ]. The typical presentation involves sharp ulnar pain after missing a swing or striking a stationary object [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/22\">",
"     22",
"    </a>",
"    ]. The pain progresses to a dull, ill-defined discomfort during sports-related, but not daily activities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On examination there is point tenderness over the hook of the hamate, located just distal and lateral to the pisiform (",
"    <a class=\"graphic graphic_figure graphicRef69097 \" href=\"mobipreview.htm?1/31/1527\">",
"     figure 5",
"    </a>",
"    ). Callus or skin changes from repeated trauma may be noted overlying the area of the hamate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/26\">",
"     26",
"    </a>",
"    ]. Associated ulnar motor and sensory deficit may be present (eg, paresthesia in",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pain with resisted flexion of the fourth and fifth digits) (",
"    <a class=\"graphic graphic_table graphicRef53902 \" href=\"mobipreview.htm?24/11/24763\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/16,26\">",
"     16,26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/25/9620?source=see_link\">",
"     \"Hamate fractures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fractures of the hook of the hamate are best visualized on the 45 degrees supination oblique view, the carpal tunnel view, or with CT (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59836 \" href=\"mobipreview.htm?18/28/18894\">",
"     image 8",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75387 \" href=\"mobipreview.htm?26/27/27071\">",
"     image 9",
"    </a>",
"    ). Hamate body fractures are readily apparent on routine views (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66660 \" href=\"mobipreview.htm?3/53/3935\">",
"     image 10",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/25/9620?source=see_link&amp;anchor=H5#H5\">",
"     \"Hamate fractures\", section on 'Radiographic findings'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Indications for evaluation by a hand surgeon and initial treatment of these injuries is discussed separately (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/25/9620?source=see_link&amp;anchor=H6#H6\">",
"     \"Hamate fractures\", section on 'Indications for surgical referral'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/25/9620?source=see_link&amp;anchor=H7#H7\">",
"     \"Hamate fractures\", section on 'Initial treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Child abuse",
"    </span>",
"    &nbsp;&mdash;&nbsp;The possibility of child abuse should be considered in all children with fractures, particularly those younger than three years of age and when there are inconsistencies in the history. Although most distal radial fractures in children are unintentional and occur after falls on an outstretched hand, metaphyseal chip or \"corner\" fractures are highly specific for child abuse (",
"    <a class=\"graphic graphic_figure graphicRef50274 \" href=\"mobipreview.htm?28/62/29667\">",
"     figure 6",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/19/24890?source=see_link\">",
"     \"Physical abuse in children: Diagnostic evaluation and management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/30/13802?source=see_link\">",
"     \"Orthopedic aspects of child abuse\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Suspicion of child abuse should prompt involvement of an experienced child protection team (eg, social worker, nurse, physician with more extensive experience in the management of child abuse), if available. In many parts of the world (including the US, UK, and Australia), a mandatory report to appropriate governmental authorities is also required for cases of suspected abuse. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/5/35927?source=see_link&amp;anchor=H3#H3\">",
"     \"Child abuse: Social and medicolegal issues\", section on 'Reporting suspected abuse'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     LIGAMENTOUS AND CAPSULAR INJURIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The complex anatomic relationship of the carpal bones and multiple ligamentous attachments helps to stabilize the wrist while permitting considerable mobility. However, when exposed to forces outside of their physiologic range as may occur in a fall, motor vehicle accident, or high-impact contact with another player, ball, or other object, ligamentous injury can occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/8,27\">",
"     8,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ligamentous injuries encompass stretching (simple sprain) and partial or complete tears, which lead to instability and dislocation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Simple sprain",
"    </span>",
"    &nbsp;&mdash;&nbsp;A simple sprain involves stretching of the supporting ligaments of the radiocarpal joint; the usual mechanism is a fall on an extended wrist. Simple sprains are associated with mild pain or stiffness and normal range of motion. A detailed history and clinical examination must be performed to exclude more serious injuries (eg, type I Salter-Harris distal radius fracture [ (",
"    <a class=\"graphic graphic_figure graphicRef54582 \" href=\"mobipreview.htm?20/55/21361\">",
"     figure 1",
"    </a>",
"    )], carpal fracture, or carpal instability) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/28-31\">",
"     28-31",
"    </a>",
"    ]. Patients with a simple sprain should have no bony tenderness over the distal radius and normal plain radiographs of the wrist (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61652 \" href=\"mobipreview.htm?10/32/10767\">",
"     image 11",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Fractures'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H14\">",
"     'Wrist instability and dislocation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Bases upon our experience, most of these injuries resolve within two weeks with conservative therapy including rest, ice, immobilization of the wrist in 20 degrees of dorsiflexion and gentle flexion and extension of the wrist as pain allows. If pain persists, referral to a sports medicine specialist or orthopedic surgeon is warranted.",
"   </p>",
"   <p>",
"    A detailed history and clinical examination must be performed to exclude more serious injuries (eg, type I Salter-Harris distal radius fracture (",
"    <a class=\"graphic graphic_figure graphicRef54582 \" href=\"mobipreview.htm?20/55/21361\">",
"     figure 1",
"    </a>",
"    ), carpal fracture, carpal instability) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Fractures'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H14\">",
"     'Wrist instability and dislocation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Wrist instability and dislocation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carpal instability refers to the failure of the wrist joint to properly transfer kinematic loads and misalignment of the carpal bones [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/32\">",
"     32",
"    </a>",
"    ]. Frank dislocations, which are closely related, involve the loss of contact between one or more carpal bones [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Traumatic wrist instability is rare in children. However, they may occur in adolescents, usually in association with distal radius physeal injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/22\">",
"     22",
"    </a>",
"    ]. Acute dislocations also may be accompanied by fractures of the radial shaft (Galeazzi fracture).",
"   </p>",
"   <p>",
"    Traumatic wrist instability is most likely to occur in contact sports and those that require twisting of the wrist (football, basketball, rugby, ice hockey, tennis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/8,27\">",
"     8,27",
"    </a>",
"    ]. Injuries also can be caused by repetitive loading with the wrist in extension (eg, gymnastics) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Carpal instabilities and dislocations share some features with wrist sprains, but are distinct disorders. Similar to simple sprains, the typical mechanism of injury for carpal instability is a fall on an extended wrist. Radiographs in patients with instability are usually normal, but must be carefully reviewed for malalignment (",
"    <a class=\"graphic graphic_figure graphicRef80973 \" href=\"mobipreview.htm?23/5/23637\">",
"     figure 7",
"    </a>",
"    ). In contrast to simple sprains, the pain of instability persists, and often is made worse by physical therapy.",
"   </p>",
"   <p>",
"    A high index of suspicion is necessary to permit early identification and appropriate therapy of ligamentous injuries. Untreated injuries may result in chronic pain and functional deficits. The early involvement of a hand specialist in the management of wrist instability or dislocation optimizes long-term outcome.",
"   </p>",
"   <p>",
"    Carpal instabilities are classified according to the involved joints [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21,34\">",
"     21,34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Between joints in the same row (eg, scapholunate instability, lunotriquetral instability)",
"     </li>",
"     <li>",
"      Between the proximal and distal rows (midcarpal instability)",
"     </li>",
"     <li>",
"      Between joints in the same row and between proximal and distal rows (this category includes all of the carpal dislocations, of which perilunate dislocations are most common)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Provocative examination techniques can be helpful in localizing the instability. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/43/32440?source=see_link&amp;anchor=H13#H13\">",
"     \"Evaluation of wrist pain and injury in children and adolescents\", section on 'Integrity of ligaments'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Lateral and AP radiographs can be diagnostic. Special instability views with the wrist in certain positions may be necessary to appreciate malalignments resulting from partial tears [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21\">",
"     21",
"    </a>",
"    ]. MRI is also useful and is gaining popularity as a diagnostic tool [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/43/32440?source=see_link&amp;anchor=H23#H23\">",
"     \"Evaluation of wrist pain and injury in children and adolescents\", section on 'Imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Scapholunate",
"    </span>",
"    &nbsp;&mdash;&nbsp;With increased levels of athletic competition, injuries to the scapholunate are becoming more common in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/20\">",
"     20",
"    </a>",
"    ]. The importance of early diagnosis and treatment cannot be overemphasized [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Scapholunate injuries are common in collision and contact sports. They result from excessive wrist extension and ulnar deviation with intercarpal supination, such as a fall on a pronated hand or jamming into another athlete [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/16,21\">",
"     16,21",
"    </a>",
"    ]. With disruption of the scapholunate ligament, the scaphoid assumes a flexed position and the lunate and triquetrum extend, producing a dorsal intercalated segment instability (DISI) deformity (",
"    <a class=\"graphic graphic_figure graphicRef80973 \" href=\"mobipreview.htm?23/5/23637\">",
"     figure 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21\">",
"     21",
"    </a>",
"    ]. Scapholunate injuries are associated with negative ulnar variance (ie, when the ulna is shorter than the radius) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Examination findings include wrist swelling, focal pain and tenderness (out of proportion to the injury), decreased range of motion, decreased grip strength, and asymmetric clicking with the scaphoid stability test, although patients with scapholunate ligament injury often cannot tolerate this test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/16,20,21,25,37\">",
"     16,20,21,25,37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/43/32440?source=see_link&amp;anchor=H14#H14\">",
"     \"Evaluation of wrist pain and injury in children and adolescents\", section on 'Scapholunate'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Abnormalities on the AP wrist radiograph include increased scapholunate distance (&gt;3 mm, (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52517 \" href=\"mobipreview.htm?14/30/14816\">",
"     image 12",
"    </a>",
"    )) and flexed scaphoid [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/20\">",
"     20",
"    </a>",
"    ]; the lateral view may demonstrate increased scapholunate angle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21\">",
"     21",
"    </a>",
"    ] and the DISI deformity (",
"    <a class=\"graphic graphic_figure graphicRef80973 \" href=\"mobipreview.htm?23/5/23637\">",
"     figure 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/16\">",
"     16",
"    </a>",
"    ]. All views should be compared with radiographs of the uninjured wrist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21,25\">",
"     21,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Plain radiographs may be normal in children with partial scapholunate injuries. In addition, scapholunate distance in children can be difficult to interpret because of eccentric ossification and the chondral nature of the carpus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/20\">",
"     20",
"    </a>",
"    ]. If scapholunate injuries are suspected, MRI imaging may be more useful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most scapholunate ligament injuries have normal radiographs and are treated conservatively with immobilization of the wrist in 20 degrees of dorsiflexion for two to six weeks. However, a complete tear or a partial ligament injury which fails to respond to conservative therapy is an indication for arthroscopic evaluation and possible surgical reconstruction of the ligament [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/38\">",
"     38",
"    </a>",
"    ]. Return to play guidelines vary depending on the severity of the illness and the demands of the sport and should be done under the guidance of a sports medicine physician or a hand specialist.",
"   </p>",
"   <p>",
"    Scapholunate dislocation or dissociation requires prompt consultation with an orthopedic or hand surgeon, but can be stabilized with a thumb spica splint (",
"    <a class=\"graphic graphic_figure graphicRef79534 \" href=\"mobipreview.htm?26/19/26943\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Lunotriquetral",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injuries to the lunotriquetral ligament usually result from sudden axial loading with wrist extension and radial deviation with intercarpal pronation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The typical presentation includes a fall on an outstretched hand and subsequent ulnar-sided wrist pain, weakness, giving way, and a clicking sound [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21,37\">",
"     21,37",
"    </a>",
"    ]. Examination findings include tenderness of the lunotriquetral ligament (in the ulnar snuff box: the sulcus distal to the ulnar head formed by the extensor carpi ulnaris and flexor carpi ulnaris tendons), clicking produced by passively loading the wrist from radial to ulnar deviation, and a positive lunotriquetral shear test (",
"    <a class=\"graphic graphic_figure graphicRef70789 \" href=\"mobipreview.htm?19/37/20048\">",
"     figure 8",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/16,21\">",
"     16,21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/43/32440?source=see_link\">",
"     \"Evaluation of wrist pain and injury in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Radiographs are usually normal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21\">",
"     21",
"    </a>",
"    ]. Occasionally, a stepoff may be noted along the proximal carpal row [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21\">",
"     21",
"    </a>",
"    ]. Lunotriquetral injury is associated with positive ulnar variance (ie, an ulna that is longer than the radius). Magnetic resonance imaging can be helpful in assessing these ligamentous injuries especially when combined with a midcarpal arthrogram [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/39\">",
"     39",
"    </a>",
"    ]. This technique is superior to radial carpal arthrogram and has been noted to have a sensitivity of 93 percent for lunotriquetral ligament injuries.",
"   </p>",
"   <p>",
"    The majority of lunotriquetral ligament injuries is also treated conservatively with long-arm immobilization of the wrist in 20 degrees of dorsiflexion and elbow in 90 degrees of flexion for four to six weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21,40\">",
"     21,40",
"    </a>",
"    ]. Arthroscopic evaluation and possible surgical reconstruction is indicated for complete tears or partial tears which do not respond to immobilization.&nbsp;Return to play guidelines vary depending upon the severity of the illness and the demands of the sport and should occur with guidance from a sports medicine physician or a hand specialist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Midcarpal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Midcarpal instability results from injury to the ligaments between the proximal and distal rows of carpal bones. Midcarpal instability can be palmar or dorsal; palmar instability is more common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical features include ulnar wrist pain, a sulcus in the dorsal ulnar wrist border, pain with resisted active extension of the fingers when the wrist is flexed, and a painful clunk when the wrist is actively deviated ulnarly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21,25\">",
"     21,25",
"    </a>",
"    ]. The latter finding also may occur with lunotriquetral ligament tears, distal radio-ulnar joint injuries, triangular fibrocartilage complex tears, and ulnar impaction syndrome. Cineradiography or MRI can help to distinguish among these possibilities. Plain radiographs may demonstrate a volar intercalated segment instability pattern [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21\">",
"     21",
"    </a>",
"    ]. Midcarpal instability although not as common as scapholunate or lunotriquetral ligament injuries, usually signifies a more severe injury.",
"   </p>",
"   <p>",
"    Although initial treatment is typically nonoperative, referral to a hand specialist is indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Perilunate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perilunate dislocation (dislocation of the carpus) results from excessive radiocarpal extension and ulnar deviation with intercarpal supination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21\">",
"     21",
"    </a>",
"    ]. It should be suspected when significant swelling and decreased range of motion are observed after trauma in a contact sport [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21\">",
"     21",
"    </a>",
"    ]. Perilunate dislocation may be complicated by carpal tunnel syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/15/42230?source=see_link\">",
"     \"Clinical manifestations and diagnosis of carpal tunnel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The lateral radiograph demonstrates dorsal displacement of the capitate on the lunate (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77044 \" href=\"mobipreview.htm?31/25/32145\">",
"     image 13",
"    </a>",
"    ) or, in palmar lunate dislocation, palmar displacement of the lunate into the carpal tunnel [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21\">",
"     21",
"    </a>",
"    ]. Perilunate dislocation is inherently a severe injury as all ligamentous attachments to the lunate, including both the scapholunate and lunotriquetral ligaments have been severed. Referral to a hand surgeon is important as prompt surgical intervention to establish anatomic alignment is necessary to reduce the long term risk of avascular necrosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     DRUJ and TFCC injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Distal radioulnar joint (DRUJ) and triangular fibrocartilage complex (TFCC) injuries are often discussed together because of their close anatomic relationship and overlapping symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/13\">",
"     13",
"    </a>",
"    ]. Because the TFCC is the primary stabilizer of the DRUJ, injury to the TFCC may result in DRUJ instability. DRUJ instability also can occur with other injuries (eg, distal radius fracture).",
"   </p>",
"   <p>",
"    Chronic DRUJ and TFCC injuries are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/60/38855?source=see_link\">",
"     \"Causes of chronic wrist pain in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     DRUJ injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute injuries to the distal radioulnar joint (DRUJ) often involve a fall on an extended wrist, particularly when the wrist is pronated. Acute DRUJ injuries are common in motor vehicle accidents, impact sports, and racquet, stick, and club sports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/8\">",
"     8",
"    </a>",
"    ]. They may be accompanied by distal radial fractures (Galeazzi fracture (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef54885 \" href=\"mobipreview.htm?35/49/36627\">",
"     image 1",
"    </a>",
"    )).",
"   </p>",
"   <p>",
"    Patients with DRUJ injuries usually present with complaints of pain on supination and pronation of the wrist. DRUJ instability may be partial or complete. Dislocation or subluxation of the DRUJ may be dorsal or palmar [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Examination findings include positive DRUJ compression (",
"    <a class=\"graphic graphic_figure graphicRef78662 \" href=\"mobipreview.htm?4/61/5074\">",
"     figure 9",
"    </a>",
"    ) and piano key tests. The piano key test is performed on a pronated wrist; it is positive if ballottement of the ulnar head in a palmar direction produces little resistance compared with the other side. Alternatively, the patient forcibly presses both palms into the examination table; exaggerated dorsal-palmar translation compared with the opposite side indicates DRUJ instability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/13,21\">",
"     13,21",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    Imaging of the DRUJ begins with plain radiographs, although plain radiographs are often normal, particularly with mild DRUJ instability. DRUJ dislocation can be seen on PA and lateral wrist radiographs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/16\">",
"     16",
"    </a>",
"    ]. MRI can demonstrate DRUJ subluxation as well at the surrounding soft tissues including the TFCC, lunotriquetral ligaments, and articular surfaces of the carpus and ulna.",
"   </p>",
"   <p>",
"    Isolated dislocation can be treated with reduction (often requiring the use of regional or general anesthesia) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/42\">",
"     42",
"    </a>",
"    ] followed by cast immobilization for six weeks. DRUJ dislocation accompanied by fracture of the radial shaft (Galeazzi fracture) requires operative reduction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     TFCC injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar to distal radioulnar joint (DRUJ) injuries, acute injuries to the triangular fibrocartilage complex (TFCC) often involve a fall on an extended wrist, particularly when the wrist is pronated. In addition, sudden excessive pronation or supination may result in acute TFCC disruption and peripheral tears [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/8\">",
"     8",
"    </a>",
"    ]. Peripheral tears may result in DRUJ instability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The history in patients with TFCC tears often involves repetitive loading with heavy lifting in ulnar deviation or ulnar loading of the wrist (eg, in racquet sports or golf) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/43\">",
"     43",
"    </a>",
"    ]. Patients complain of a dull aching sensation radiating to the dorsal wrist and grip weakness that may be associated with clicking mechanical sensations during pronation and supination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical manifestations of TFCC injury include tenderness in the hollow between the pisiform and the ulnar styloid on the ulnar border of the wrist (",
"    <a class=\"graphic graphic_figure graphicRef63443 \" href=\"mobipreview.htm?15/39/15986\">",
"     figure 2",
"    </a>",
"    ) and pain with TFCC compression (",
"    <a class=\"graphic graphic_figure graphicRef50337 \" href=\"mobipreview.htm?42/0/43009\">",
"     figure 10",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/43/32440?source=see_link&amp;anchor=H17#H17\">",
"     \"Evaluation of wrist pain and injury in children and adolescents\", section on 'TFCC tears'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Plain radiographic findings are helpful, but often not diagnostic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21\">",
"     21",
"    </a>",
"    ]. Associated radiographic abnormalities may include widening of the DRUJ space on the AP view,",
"    <span class=\"nowrap\">",
"     dislocation/subluxation",
"    </span>",
"    on the lateral view, positive ulnar variance, and fractures of the ulnar styloid.",
"   </p>",
"   <p>",
"    Magnetic resonance imaging (MRI) demonstrates the TFCC, surrounding ligaments, DRUJ, and articular surfaces of the carpus and ulna. TFCC tears are viewed after the administration of intraarticular gadolinium contrast. High signal within the TFCC (which appears black on fluid-sensitive MRI sequences) or contrast fluid communicating between the radioulnar and radiocarpal joint signifies a TFCC tear.",
"   </p>",
"   <p>",
"    Acute TFCC tears are treated initially with immobilization in a sugar tong splint followed by cast for six weeks to allow the TFCC to heal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/44\">",
"     44",
"    </a>",
"    ]. Because the blood supply to the TFCC is from the periphery toward the center, healing is more likely with peripheral tears; tears in the avascular central zone rarely heal. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/54/15208?source=see_link&amp;anchor=H12#H12\">",
"     \"Splinting of musculoskeletal injuries\", section on 'Sugar tong splints'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If patients are still not improved with conservative immobilization, arthroscopy with either debridement or repair of the TFCC is indicated. Arthroscopy permits better visualization of the TFCC than open procedures. In one small series of 16 competitive athletes TFCC injuries, arthroscopic debridement or repair was associated with pain relief and return to play within an average of three months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     NEUROVASCULAR INJURIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trauma to the wrist may be associated with injury to the median, ulnar nerves, or radial nerve. Median nerve injury may occur with dislocation of the lunate into the carpal tunnel. Ulnar nerve injury may occur with fractures of the pisiform or hamate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/46\">",
"     46",
"    </a>",
"    ]. Radial nerve injury may occur with direct trauma.",
"   </p>",
"   <p>",
"    Direct impact to the hypothenar eminence (eg, from catching a baseball, in handball) can cause damage to the ulnar artery and superficial palmar arch. Clinical features include complaints of pain in the palm that may radiate to the forearm, coldness of the digits, and an abnormal modified Allen test (",
"    <a class=\"graphic graphic_figure graphicRef70306 \" href=\"mobipreview.htm?3/61/4049\">",
"     figure 11",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/47\">",
"     47",
"    </a>",
"    ]. Prompt consultation with a hand surgeon is required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     RETURN TO PLAY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decisions regarding return to play after an acute wrist injury involve several factors. These include the type of injury, completeness of healing, extent of rehabilitation, age, sport, special skills, and level of competition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/8/32905/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As a general rule, the basic requirements for returning to competition include complete healing of the injury and thorough rehabilitation with restoration of a painless functional range of motion and near-normal strength. The rehabilitated wrist, whenever possible, should be protected from further trauma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/20/7491?source=see_link\">",
"       \"Patient information: Common wrist injuries (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Causes of acute wrist injury in children and adolescents include fractures, simple sprains, and ligamentous instabilities (",
"      <a class=\"graphic graphic_table graphicRef57608 \" href=\"mobipreview.htm?26/8/26765\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Fractures of the distal radius are the most common fractures in children and adolescents. Clinical findings include point tenderness, swelling, ecchymosis, and decreased grip strength. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Distal radius'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The distal radial growth plate (physis) is particularly susceptible to injury during the adolescent growth spurt. Distal radial physeal fractures may be associated with premature closure and growth arrest of the distal radius; the risk increases with the severity of the fracture. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Physeal fractures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Scaphoid fractures should be considered in adolescents with radial pain after a fall. Characteristic examination findings include tenderness of the anatomic snuff box, decreased range of motion, pain with radial deviation or extension of the wrist, and a positive scaphoid compression test. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Scaphoid fractures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fractures of the hook of the hamate should be considered in skeletally mature players of racquet, stick, or club sports who complain of ulnar-sided palmar pain after missing a swing or striking an object. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Hamate fractures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ligamentous and capsular injuries are uncommon in children and adolescents, but should be considered when the mechanism of injury involves high-impact contact. Many of these injuries warrant prompt referral to an orthopedic or hand surgeon. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Ligamentous and capsular injuries'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The basic requirements for returning to competition after an acute injury include complete healing of the injury and thorough rehabilitation with restoration of a painless functional range of motion and near-normal strength. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Return to play'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/1\">",
"      Gill TJ 4th, Micheli LJ. The immature athlete. Common injuries and overuse syndromes of the elbow and wrist. Clin Sports Med 1996; 15:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/2\">",
"      Mastey RD, Weiss AP, Akelman E. Primary care of hand and wrist athletic injuries. Clin Sports Med 1997; 16:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/3\">",
"      Huurman WW. Injuries to the hand and wrist. Adolesc Med 1998; 9:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/4\">",
"      Le TB, Hentz VR. Hand and wrist injuries in young athletes. Hand Clin 2000; 16:597.",
"     </a>",
"    </li>",
"    <li>",
"     Rao SB, Crawford AH. Traumatic and acquired wrist disorders in children. In: The Wrist and Its Disorders, Lichtman A.  (Ed), WB Saunders, Philadelphia 1999. p.540.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/6\">",
"      Skaggs DL, Loro ML, Pitukcheewanont P, et al. Increased body weight and decreased radial cross-sectional dimensions in girls with forearm fractures. J Bone Miner Res 2001; 16:1337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/7\">",
"      Goulding A, Jones IE, Taylor RW, et al. Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study. J Pediatr 2001; 139:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/8\">",
"      Werner SL, Plancher KD. Biomechanics of wrist injuries in sports. Clin Sports Med 1998; 17:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/9\">",
"      Lawson GM, Hajducka C, McQueen MM. Sports fractures of the distal radius--epidemiology and outcome. Injury 1995; 26:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/10\">",
"      Call&eacute; SC, Evans JT. Snowboarding trauma. J Pediatr Surg 1995; 30:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/11\">",
"      Call&eacute; SC, Eaton RG. Wheels-in-line roller skating injuries. J Trauma 1993; 35:946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/12\">",
"      Pershad J, Monroe K, King W, et al. Can clinical parameters predict fractures in acute pediatric wrist injuries? Acad Emerg Med 2000; 7:1152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/13\">",
"      Parmelee-Peters K, Eathorne SW. The wrist: common injuries and management. Prim Care 2005; 32:35.",
"     </a>",
"    </li>",
"    <li>",
"     Amadio PC, Taleisnki J. Fractures of the carpal bones. In: Operative Hand Surgery, Green DP.  (Ed), Churchill Livingstone, New York 1999. p.809.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/15\">",
"      Christodoulou AG, Colton CL. Scaphoid fractures in children. J Pediatr Orthop 1986; 6:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/16\">",
"      Nguyen DT, McCue FC 3rd, Urch SE. Evaluation of the injured wrist on the field and in the office. Clin Sports Med 1998; 17:421.",
"     </a>",
"    </li>",
"    <li>",
"     Rettig AC, Weidenbener EJ, Stone JA.. Epidemiology of hand injuries in sports. In: Hand Injuries in Athletes, Strickland JW, Rettig AC.  (Eds), WB Saunders, Philadelphia 1992. p.37.",
"    </li>",
"    <li>",
"     Eiff MP, Hatch RL, Calmbach WL. Carpal fractures: Fracture management for primary care. In: Pediatric Fracture, WB Saunders, Philadelphia 251.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/19\">",
"      Gholson JJ, Bae DS, Zurakowski D, Waters PM. Scaphoid fractures in children and adolescents: contemporary injury patterns and factors influencing time to union. J Bone Joint Surg Am 2011; 93:1210.",
"     </a>",
"    </li>",
"    <li>",
"     Waters PM. The upper limb. In: Lovell and Winter's Pediatric Orthopaedics, 6th, Morrissy RT, Weinstein SL.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.921.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/21\">",
"      Rettig AC. Athletic injuries of the wrist and hand. Part I: traumatic injuries of the wrist. Am J Sports Med 2003; 31:1038.",
"     </a>",
"    </li>",
"    <li>",
"     Garcia-Moral CA, Green NE, Fox JA.. Hand and wrist. In: Care of the Young Athlete, Sullivan JA, Anderson SJ.  (Eds), American Academy of Orthopedic Surgeons and American Academy of Pediatrics, 2000. p.349.",
"    </li>",
"    <li>",
"     Eiff MP, Hatch RL, Calmbach WL. Carpal Fractures: Fracture Management for Primary Care, WB Saunders, Philadelphia 1999. p.65.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/24\">",
"      Rettig ME, Dassa GL, Raskin KB, Melone CP Jr. Wrist fractures in the athlete. Distal radius and carpal fractures. Clin Sports Med 1998; 17:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/25\">",
"      Daniels JM 2nd, Zook EG, Lynch JM. Hand and wrist injuries: Part I. Nonemergent evaluation. Am Fam Physician 2004; 69:1941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/26\">",
"      Morgan WJ, Slowman LS. Acute hand and wrist injuries in athletes: evaluation and management. J Am Acad Orthop Surg 2001; 9:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/27\">",
"      Rettig AC, Patel DV. Epidemiology of elbow, forearm, and wrist injuries in the athlete. Clin Sports Med 1995; 14:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/28\">",
"      Musharafieh RS, Macari G. Salter-Harris I fractures of the distal radius misdiagnosed as wrist sprain. J Emerg Med 2000; 19:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/29\">",
"      De Schrijver F, De Smet L. Fracture of the hook of the hamate, often misdiagnosed as \"wrist sprain\". J Emerg Med 2001; 20:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/30\">",
"      Jones WA. Beware the sprained wrist. The incidence and diagnosis of scapholunate instability. J Bone Joint Surg Br 1988; 70:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/31\">",
"      Guly HR. Injuries initially misdiagnosed as sprained wrist (beware the sprained wrist). Emerg Med J 2002; 19:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/32\">",
"      Ruby, LK, Cooney, WP, An, KN, et al. Relative motion of selected carpal bones: A kinematic analysis of the normal wrist. J Hand Surg 1988; 13A:1.",
"     </a>",
"    </li>",
"    <li>",
"     Watson K, Idler R. The Wrist, Lippincott Williams &amp; Wilkins, Philadelphia 2001. p.203.",
"    </li>",
"    <li>",
"     Garcia-Elias M. Carpal instabilities and dislocations. In: Green's Operative Hand Surgery, Churchill Livingstone, New York 1999. p.865.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/35\">",
"      Emery KH. Imaging of sports injuries of the upper extremity in children. Clin Sports Med 2006; 25:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/36\">",
"      Cohen MS. Ligamentous injuries of the wrist in the athlete. Clin Sports Med 1998; 17:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/37\">",
"      Dobyns, JH, Linscheid, RL, Chao EY, et al. Traumatic instability of the wrist. Instr Course Lect 1975; 24:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/38\">",
"      Geissler WB, Freeland AE, Savoie FH, et al. Intracarpal soft-tissue lesions associated with an intra-articular fracture of the distal end of the radius. J Bone Joint Surg Am 1996; 78:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/39\">",
"      Levinsohn EM, Rosen ID, Palmer AK. Wrist arthrography: value of the three-compartment injection method. Radiology 1991; 179:231.",
"     </a>",
"    </li>",
"    <li>",
"     Moskal MJ. Chapter 13: Management of lunotriquetral instability. In: Wrist Arthroscopy, Geissler W.  (Ed), Springer Science, Medford 2005. p.94.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/41\">",
"      Dell PC. Traumatic disorders of the distal radioulnar joint. Clin Sports Med 1992; 11:141.",
"     </a>",
"    </li>",
"    <li>",
"     Loftus JB, Palmer AK. Disorders of the distal radioulnar joint and triangular fibrocartilage complex: An overview. In: The Wrist and Its Disorders, Lichtman A.  (Ed), WB Saunders, Philadelphia 1999. p.385.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/43\">",
"      Cober SR, Trumble TE. Arthroscopic repair of triangular fibrocartilage complex injuries. Orthop Clin North Am 2001; 32:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/44\">",
"      Bae DS, Waters PM. Pediatric distal radius fractures and triangular fibrocartilage complex injuries. Hand Clin 2006; 22:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/45\">",
"      McAdams TR, Swan J, Yao J. Arthroscopic treatment of triangular fibrocartilage wrist injuries in the athlete. Am J Sports Med 2009; 37:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/46\">",
"      Ritchie JV, Munter DW. Emergency department evaluation and treatment of wrist injuries. Emerg Med Clin North Am 1999; 17:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/8/32905/abstract/47\">",
"      Nuber GW, Assenmacher J, Bowen MK. Neurovascular problems in the forearm, wrist, and hand. Clin Sports Med 1998; 17:585.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6512 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-906C751B57-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_8_32905=[""].join("\n");
var outline_f32_8_32905=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      FRACTURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Distal radius",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Metaphyseal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Physeal fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Distal ulna fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Carpal fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Scaphoid fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Triquetral fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Hamate fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Child abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      LIGAMENTOUS AND CAPSULAR INJURIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Simple sprain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Wrist instability and dislocation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Scapholunate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Lunotriquetral",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Midcarpal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Perilunate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      DRUJ and TFCC injuries",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - DRUJ injuries",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - TFCC injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      NEUROVASCULAR INJURIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      RETURN TO PLAY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6512\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6512|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?23/32/24079\" title=\"diagnostic image 1\">",
"      Distal radius torus fx",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?28/41/29343\" title=\"diagnostic image 2\">",
"      Distal radius greenstick fx",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?8/0/8194\" title=\"diagnostic image 3\">",
"      Ulnar styloid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?12/45/13010\" title=\"diagnostic image 4\">",
"      Scaphoid fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?5/53/5983\" title=\"diagnostic image 5\">",
"      Triquetral fracture difficulty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?43/6/44142\" title=\"diagnostic image 6\">",
"      Triquetral fracture oblique xray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?30/31/31230\" title=\"diagnostic image 7\">",
"      Triquetral fracture lateral xray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?18/28/18894\" title=\"diagnostic image 8\">",
"      Hook of hamate fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?26/27/27071\" title=\"diagnostic image 9\">",
"      3D reconstruction CT hamate fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?3/53/3935\" title=\"diagnostic image 10\">",
"      Hamate body fracture xray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?10/32/10767\" title=\"diagnostic image 11\">",
"      Normal wrist radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?14/30/14816\" title=\"diagnostic image 12\">",
"      Scapholunate dissociation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?31/25/32145\" title=\"diagnostic image 13\">",
"      Perilunate dislocation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?35/49/36627\" title=\"picture 1\">",
"      Pediatric Galeazzi fracture and dislocation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6512|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?20/55/21361\" title=\"figure 1\">",
"      Salter-Harris classification system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?15/39/15986\" title=\"figure 2\">",
"      Anatomy of the triangular fibrocartilage complex",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/19/26943\" title=\"figure 3\">",
"      Thumb spica splint 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/34/27172\" title=\"figure 4\">",
"      Anatomy wrist dorsal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?1/31/1527\" title=\"figure 5\">",
"      Anatomy of the volar aspect of the wrist",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/62/29667\" title=\"figure 6\">",
"      Corner fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?23/5/23637\" title=\"figure 7\">",
"      Carpal bone angles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/37/20048\" title=\"figure 8\">",
"      Lunotriquetral shear test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/61/5074\" title=\"figure 9\">",
"      Distal radioulnar joint compression test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?42/0/43009\" title=\"figure 10\">",
"      Triangular fibrocartilage complex compression test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?3/61/4049\" title=\"figure 11\">",
"      Modified Allen test",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6512|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?26/8/26765\" title=\"table 1\">",
"      Acute wrist injury children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?24/11/24763\" title=\"table 2\">",
"      Elbow sensation strength",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/60/38855?source=related_link\">",
"      Causes of chronic wrist pain in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/5/35927?source=related_link\">",
"      Child abuse: Social and medicolegal issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/15/42230?source=related_link\">",
"      Clinical manifestations and diagnosis of carpal tunnel syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/8/42120?source=related_link\">",
"      Diagnosis and assessment of distal forearm fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/43/32440?source=related_link\">",
"      Evaluation of wrist pain and injury in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/40/20104?source=related_link\">",
"      General principles of fracture management: Fracture patterns and description in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/25/9620?source=related_link\">",
"      Hamate fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/14/14569?source=related_link\">",
"      Initial management of distal forearm fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/30/13802?source=related_link\">",
"      Orthopedic aspects of child abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/49/4886?source=related_link\">",
"      Overview of carpal fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/20/7491?source=related_link\">",
"      Patient information: Common wrist injuries (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/19/24890?source=related_link\">",
"      Physical abuse in children: Diagnostic evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/51/1848?source=related_link\">",
"      Scaphoid fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/54/15208?source=related_link\">",
"      Splinting of musculoskeletal injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/55/36723?source=related_link\">",
"      Triquetral fractures",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_8_32906="Dermatofibroma - shin";
var content_f32_8_32906=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F80587%7EDERM%2F68729%7EDERM%2F80575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F80587%7EDERM%2F68729%7EDERM%2F80575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dermatofibroma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This firm, hyperpigmented papule on the shin is a dermatofibroma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dermatofibroma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This oval, hyperpigmented, firm papule is a dermatofibroma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dermatofibroma \"dimple sign\"",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 320px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A \"dimple\" is elicited on compression of this dermatofibroma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd Edition, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_8_32906=[""].join("\n");
var outline_f32_8_32906=null;
var title_f32_8_32907="Endothelial cell disorders";
var content_f32_8_32907=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F63061&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F63061&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Endothelial cell disorders",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Hereditary",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperhomocysteinemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fabry's disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plasminogen activator deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plasminogen activator inhibitor excess",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Protein S deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Activated Protein C resistance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nitric oxide synthase deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Acquired",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trauma: mechanical, biochemical, toxin, infectious",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Atherosclerosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diabetes mellitus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dyslipidemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Immune-mediated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Collagen vascular diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombotic thrombocytopenic purpura",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Behcets disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Heparin-mediated antibodies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antiphospholipid syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Transplant vasculopathy",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_8_32907=[""].join("\n");
var outline_f32_8_32907=null;
var title_f32_8_32908="Occupational HIV infection";
var content_f32_8_32908=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F60942&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F60942&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Healthcare personnel with documented and possible occupationally acquired AIDS/HIV infection, by occupation, 1981-2010",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Occupation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Documented",
"       </td>",
"       <td class=\"subtitle1\">",
"        Possible",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nurse",
"       </td>",
"       <td>",
"        24",
"       </td>",
"       <td>",
"        36",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Laboratory worker, clinical",
"       </td>",
"       <td>",
"        16",
"       </td>",
"       <td>",
"        17",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Physician, nonsurgical",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        13",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Laboratory technician, nonclinical",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Housekeeper/maintenance worker",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        14",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Technician, surgical",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Embalmer/morgue technician",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Health aide/attendant",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        15",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Respiratory therapist",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Technician, dialysis",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dental worker, including dentist",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Emergency medical technician/paramedic",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Physician, surgical",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other technician/therapist",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other healthcare occupation",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Total",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         57",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         143",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      Centers for Disease Control and Prevention. Surveillance of Occupationally Acquired HIV/AIDS in Healthcare Personnel, as of December 2010. Updated May 2011.",
"      <a href=\"file://www.cdc.gov/HAI/organisms/hiv/Surveillance-Occupationally-Acquired-HIV-AIDS.html\">",
"       file://www.cdc.gov/HAI/organisms/hiv/Surveillance-Occupationally-Acquired-HIV-AIDS.html",
"      </a>",
"      .",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_8_32908=[""].join("\n");
var outline_f32_8_32908=null;
var title_f32_8_32909="Age-adjusted death rates for diabetic hyperglycemic crises";
var content_f32_8_32909=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F68391&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F68391&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 485px\">",
"   <div class=\"ttl\">",
"    Age-adjusted death rates for diabetic hyperglycemic crises as underlying cause per 100,000 general population, United States, 1980-2005",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 465px; height: 351px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Between 1980 and 2005, the age-adjusted death rate for hyperglycemic crises in the general population declined. In 2005, the age-adjusted death rate for hyperglycemic crises was 0.8 per 100,000 general population, almost half the rate in 1980 (1.5 per 100,000).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention: Diabetes Data &amp; Trends. Retreived from file://www.cdc.gov/diabetes/statistics/mortalitydka/ fRateDKAGenAgeAdjusted.htm on February 23, 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_8_32909=[""].join("\n");
var outline_f32_8_32909=null;
var title_f32_8_32910="Melanoma 7th TNM staging";
var content_f32_8_32910=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F50225%7EONC%2F74203&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F50225%7EONC%2F74203&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Seventh (2010) TNM staging system for cutaneous melanoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\" rowspan=\"1\">",
"       Primary tumor (T)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       TX",
"      </td>",
"      <td>",
"       Primary tumor cannot be assessed (eg, curettaged or severely regressed primary)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T0",
"      </td>",
"      <td>",
"       No evidence of primary tumor",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tis",
"      </td>",
"      <td>",
"       Melanoma in situ",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"3\">",
"       T1",
"      </td>",
"      <td class=\"sublist1_start\">",
"       &le;1.0 mm",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       a: without ulceration and mitoses &lt;1/mm",
"       <sup>",
"        2",
"       </sup>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       b: with ulceration or mitoses &ge;1/mm",
"       <sup>",
"        2",
"       </sup>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"3\">",
"       T2",
"      </td>",
"      <td class=\"sublist1_start\">",
"       1.01-2.0 mm",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       a: without ulceration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       b: with ulceration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"3\">",
"       T3",
"      </td>",
"      <td class=\"sublist1_start\">",
"       2.01-4.0 mm",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       a: without ulceration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       b: with ulceration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"3\">",
"       T4",
"      </td>",
"      <td class=\"sublist1_start\">",
"       &gt;4.0 mm",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       a: without ulceration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       b: with ulceration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\" rowspan=\"1\">",
"       Regional lymph nodes (N)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       NX",
"      </td>",
"      <td>",
"       Patients in whom the regional nodes cannot be assessed (eg, previously removed for another reason)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       No regional metastases detected",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"3\">",
"       N1",
"      </td>",
"      <td class=\"sublist1_start\">",
"       One lymph node",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       a: micrometastases*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       b: macrometastases&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"4\">",
"       N2",
"      </td>",
"      <td class=\"sublist1_start\">",
"       Two or three lymph nodes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       a: micrometastases*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       b: macrometastases&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       c: in-transit met(s)/satellite(s) without metastatic lymph nodes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       N3",
"      </td>",
"      <td>",
"       Four or more metastatic lymph nodes, or matted lymph nodes, or in-transit met(s)/satellite(s) with metastatic lymph node(s)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\" rowspan=\"1\">",
"       Distant metastasis (M)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       M0",
"      </td>",
"      <td>",
"       No detectable evidence of distant metastases",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       M1a",
"      </td>",
"      <td>",
"       Metastases to skin, subcutaneous, or distant lymph node, normal serum LDH",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       M1b",
"      </td>",
"      <td>",
"       Lung metastases, normal LDH",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       M1c",
"      </td>",
"      <td>",
"       Metastasis to other visceral metastases with a normal LDH, or any distant metastases and an elevated LDH",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Note: cTNM is the clinical classification, pTNM is the pathologic classification.",
"    <div class=\"footnotes\">",
"     * Micrometastases are diagnosed after sentinel lymph node biopsy and completion lymphadenectomy (if performed).",
"     <br>",
"      &bull; Macrometastases are defined as clinically detectable lymph node metastases confirmed by therapeutic lymphadenectomy or when any lymph node metastasis exhibits gross extracapsular extension.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Seventh TNM stage groupings for cutaneous melanoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Stage",
"      </td>",
"      <td class=\"subtitle1\">",
"       Primary tumor (T)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Regional lymph nodes (N)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Distant metastasis (M)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"4\">",
"       Clinical staging*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Stage 0",
"      </td>",
"      <td>",
"       Tis",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Stage IA",
"      </td>",
"      <td>",
"       T1a",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"2\">",
"       Stage IB",
"      </td>",
"      <td>",
"       T1b",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T2a",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"2\">",
"       Stage IIA",
"      </td>",
"      <td>",
"       T2b",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T3a",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"2\">",
"       Stage IIB",
"      </td>",
"      <td>",
"       T3b",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T4a",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Stage IIC",
"      </td>",
"      <td>",
"       T4b",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Stage III",
"      </td>",
"      <td>",
"       Any T",
"      </td>",
"      <td>",
"       N1, N2, or N3",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Stage IV",
"      </td>",
"      <td>",
"       Any T",
"      </td>",
"      <td>",
"       Any N",
"      </td>",
"      <td>",
"       M1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"4\">",
"       Pathologic staging&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Stage 0",
"      </td>",
"      <td>",
"       Tis",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Stage IA",
"      </td>",
"      <td>",
"       T1a",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"2\">",
"       Stage IB",
"      </td>",
"      <td>",
"       T1b",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T2a",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"2\">",
"       Stage IIA",
"      </td>",
"      <td>",
"       T2b",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T3a",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"2\">",
"       Stage IIB",
"      </td>",
"      <td>",
"       T3b",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T4a",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Stage IIC",
"      </td>",
"      <td>",
"       T4b",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"2\">",
"       Stage IIIA",
"      </td>",
"      <td>",
"       T1-4a",
"      </td>",
"      <td>",
"       N1a",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T1-4a",
"      </td>",
"      <td>",
"       N2a",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"5\">",
"       Stage IIIB",
"      </td>",
"      <td>",
"       T1-4b",
"      </td>",
"      <td>",
"       N1a",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T1-4b",
"      </td>",
"      <td>",
"       N2a",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T1-4a",
"      </td>",
"      <td>",
"       N1b",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T1-4a",
"      </td>",
"      <td>",
"       N2b",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T1-4a",
"      </td>",
"      <td>",
"       N2c",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"4\">",
"       Stage IIIC",
"      </td>",
"      <td>",
"       T1-4b",
"      </td>",
"      <td>",
"       N1b",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T1-4b",
"      </td>",
"      <td>",
"       N2b",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T1-4b",
"      </td>",
"      <td>",
"       N2c",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Any T",
"      </td>",
"      <td>",
"       N3",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Stage IV",
"      </td>",
"      <td>",
"       Any T",
"      </td>",
"      <td>",
"       Any N",
"      </td>",
"      <td>",
"       M1",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Clinical staging includes microstaging of the primary melanoma and clinical/radiologic evaluation for metastases. By convention, it should be used after complete excision of the primary melanoma with clinical assessment for regional and distant metastases.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Pathologic staging includes microstaging of the primary melanoma and pathologic information about the regional lymph nodes after partial or complete lymphadenectomy. Pathologic Stage 0 or Stage IA patients are the exception; they do not require pathologic evaluation of their lymph nodes.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_8_32910=[""].join("\n");
var outline_f32_8_32910=null;
var title_f32_8_32911="Pulm bronchogen cyst CT II";
var content_f32_8_32911=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F82030&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F82030&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Intrapulmonary bronchogenic cyst",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 207px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADPAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5yRd5+XJNWo4VTBkJLdgKfADIdsChUH8Rq9o2lXmtaza6PocDXN7cvsTAzj3J7AetAFeztbvUr2KysIXmu5jtjgiGWY19C/Dr4J2GiCHVPHpS4usb005DlF/3z3PtXZfDzwVpvw20rYixXviSZR9ouyM+We6pnoP51rytJJIJJnLE85NAGidTmKeTBDHbWMagRwxjaAB04rMmle4Iebt2ollPl8jjPNMhtrm7YeUvXuegFADG2Hl+DRDFLOR5ERJrbtNIt4fmmO9+47VoKUQYRQo9hQBiRaHNKyvcSBMD7orUt9PtIWGIt7+pqV5ET5nYiq8t5OG2W0O5j3NAF8EgjYoAHpTWZckMenNVEFwnN/KsK/3VPNaCwJLbA2sbSY6se9AFVpgOAGY+wpjzyZwsTH60+SSSMZ+znI7ZFcXrHxQ0/RrxrfVNNvIERsGXZ8p+lAHXi6nV/miG2l+0tuAWFvc1xVv8YfAl0CG1XypM/deNh/Sug0fxp4Z1RgmnazaTOeiB8N+RoA2t5Zh8pANI7sOMU2SU5DRgOpPBU5pknnM4G0qT1BHSgBj3DK+FBOKhl1GY3EVvDFunlOAccD3NDSBLrymzke3WrFqxjv0cq5ycA7aANeTTLK2iVb+5kLsMnDYpDaaIy5kUyqeMMSRWhLp0V3GGucqw6H2qmtvpkA2SXOVHHLd6AGx2+hrkxwBAvoCKniXS522JkFuPSoJbnRApRphtHoasWt1pKQiZJokQdGkbAoA4rWpdQsvEs+nRSD7KIlkjY9TnqKs25uWOJG5HU1k+JvFGgDVjPda9YKUG35ZATVeDxPod9GVs9fsjnjJkANAG819BvaJmyy9cVEbpTkJuyfWqq6x4ctpU8zVLPYqZdhICc15540+NegaVdCPRLU6lMMgu3yIP8aAPTUiWUb4VkZu57VVvZ7HTV33+oxWvs8mP0r5h8R/FzxbrTuILv+z4CeI7b5ePr1riLu8vrmXzLu9nmc85dyaAPre9+I3hCzlaKXXcyA9UBYZqKT4peGodgTUftSHuF5FfIjDLHJ5prZTGxiM0AfaFl478O6k2LbUYlfptc7a1RqRK74wJYjzujOeK+HkuJ+AkpDjnIrb0Px14h0Rg1jqEqqD9wnIP4GgD7Jh1SGV9qthv7p7VNNHFMCJI1YeoFeB+EvjlAHEXifTQ3fz4OD+Ir2nwv4l0PxPEkmi38chIyYmYBx+FAC3WhQzkGB2hYGsW/wBOv7V2Z0WSEdCvWu4msJ4/mxwefrUJcglJVGe4PSgDgFdvu5GPepYWx04OcH3rp9R0WC8y8A8ubtg8GuZkgmgm8uaIq4PDY4NAE8NxLbOJ7dijqckDoaxPGvgbSfiJavOixaZ4jA+S4UYWY+jj+ta29thDLx0NRktECA5B6qR1oA+WNe0i90TV5tL1q2a0voTgq44YdiPUGsmaJo2xIOfWvrTx74StfiRoH2V9kPiS0Tda3JHMgH/LNj6Gvlh45re5msNUiaG4gcxukgwysODQBlsAOlFWLqBoGIIyp5BooA1I4Z7q6hstNha4uJWCRRRjLOx4xX1h8K/A8Pw28OGW5CS+J9QQNcP1Nuv/ADzX+tUvhT8OrX4d6Ymqa1Glx4quVyqnkWg9B/teprrJZJZnaacmSR+ck0AMffKwDMC7nk0sj7jsiy5zjI5xU9jZyzOCqlUPVjxW5Baw2yYiQDjB96AMyx0tz+8vGwpPCf41q7ggKxqFHtSnnk01wSMgZFADSTShXbAC5JpuoXNtpWnyX2qTx21rGu5mkOMV4rr3xkbVLm6i0AfY9DtyVm1Bxy/snuaAPXtQvrSwcJJIrznogOcf4VxPiX4q+HfD2Vu9QWS5PWG0xIw9iegr5p8S+OtT1eSSG1mkhsiSOvzye5NcmIxuycljzkmgD3DWvj5O5ddH0hFJOBLcuXI/CuMvfix4vuxk6rPCpP3YTtH6Vw2ePWj8aAOhn8b+JJnJOr3v185qE8aeIQAs989zHn7kx3A/nXPZ4pe9AHa2HinwtdYTxL4Sidjwbi0lMbj3x0NaMPgKx12CS9+HOufaLlfm/s2c+XcAd8Hoa84PPHGKktJ7iwukurGeS3uIzlXjbaQfqKAO48N+OPFvg/VwJ57oPbtiS0uScfQg12Un7QXiR7iSQWlqqkfKNp4qHwX4g0D4iGPRvGu2211l8u11Icea3RVf1NcP8RvCOoeC/EMukahtdgBJHInR0PQ0Ad9L8avFtxog1OGxt1Hm+Q10IyVVsZA54zXNah8V/HN+WH9rvEp6+UgXH5CtiSW3m+D+neGtGtzLdPcfbbjA+bPIA/l+VcDe+dcTw6baQb70ny/LjHJb0oA2oPHPj3WNRsdNtvEGo3FzNII4o1lPJPr7V9UvZLFHb20zl5Y4kEzZ+8+Bk/nXAfCH4bQeD7VdY1fZL4glGY16i2UjoPf3r0NomG6RpQWb19aAKktnHGP3mBCOSfavnb4xeNL/AFvXWsbZjbaPanbCg43nGCx9a+j1jLhor1QyN1214z8XfhxcwudT0pPOsurIoyU46/SgDwySFchpMsp75pjRBANrEDPGDVyaCWElXX5Ohz2qu+5MY5xQAm5xkeY+D15poReccnrk1NBIAxZ4wy9MGnA27ZJjZfoaAIuPs5kjHIODTNhePzFwRnkU9XjSKSOPOG9aVFZdN3dAzYoArMcMSRnFIxC4OMqakA7GmyJwBnrQA24t2idWQZQjII7U3djGF61Ir+W3zHK+lOMDMwMWSjdW7CgCqyfKS3QniprC9u9Luln026lt5lOVaNtpp17s3Kq4KoMZ96iCZViOgGc0Ae9fC/8AaGudO8vTfHcUl7ZEgLeoPni/3h/EP1+tfSenSaT4j02O+0e6t9QsZBlJIXDY+vofY1+eIXfjI4xXSeAfGmveANTF74fuWSJyPPtX5imUHoR69eRzQB9v3OkTwgtb/vFHO0jkVmusd0Ck8fzDggjkVifD345eHPFluEvCNL1EYDQzMNrE91PcV3Or2EGqRi702VPtKjd8p4egDjr/AEOKaLZbHax6ZPGa525h+z7UuQwlTgHsa7MTK+UcGOZDgqeuahu7aK7hKXCj2b0oA5GOcpcCWN2WRcFcdqwvid4Es/iJYSahpSJaeKbdM4+6t2AOh/2vQ1u6nYzafcDJ/dt91u1QQTSRyIyuySRnIYHrQB8pXCXFrPLY6hE0NxCSkkcgwyEdc0V9FfF/wNB4z0iXXtGjWPxDaJuuYlH/AB8IB1A/vAUUAepStLNO0sxMkrnkMasafa/apgMfu0Pzn+lQthSVTnHJY9a2dHZPsgWEcE8n1NAFlhuCoi7UXtStkMEUZJ6CnjltkYy54FaltZrZxh5F8y4fge1AFOCxJwJBlz29K5L4pePNH8A2W+7kWa/KnybRTy7Y4J9BWp8UfHNh8O/DD6jeYk1CcGO1gB5lkx/6COpr4f1zVtQ8R6vPq+t3Dz3Vw247jkL7D2oA6fUPEHiX4q+Ko7PULx0tJCztEpxHBGBknHsO9cv4m1NLuRdM0393otkSkKDjzCP429Sa1LCSbRfBV9qMTtFc6i32WJwcN5Y+/j2PSuSjUKgA6CgBMYH+FHpTjxxRnjHWgBAMDFHbaRilIwePzpcA9DQAmAKTHGTTiAMUvfmgBAOD65oxwT3pWyTRyMcYoAY0e7DAlXHII617l8M/EekfEeTTPCvxBXdq1rGYtL1HdhpvSKQ9z0x6/Xr4ntJOFwTjNIGlgkhubZ2iuYXEsbqcFWByCD9aAPWNF1HWofim2myWMNpqVqz2K28a4VRggNjv65r1D4YfDm08N3d3q+osl1qZclCw4TPU/WrXg02PjeDRPiAsUaa2lubS+CLgPKoxux64NddZSRG3Z5Qd5Y8UATywG4KysSG7c1RuHPmFCc+lXVS4eRWg6Y4z2FTWmlhUdZX3O3JJoApxTeYAhU5A+8avxyDaUkUNC4wykdarCxlgIUtuAztPrTh5uzEmMjoaAPN/iR8PdM+wXmp6bDlguXhXoo9RXzzeaXLbu5VhjPCV9m/3twBR1w6noRXnvjz4ZwX2nzahoy7boNuMQHUd8UAfMahTujf5SORQuUX7hOa6vWNFNsTHcQETrndxgiuZdZY1ZBkDPSgBVhtrg4bdC/QU2+hkglS3cYCjPsajl3r1PzevvVi7kub+2WeQ7hENrMfSgCgp3A49c00nkH3qUAYUgml8szSJHGPmY4AoArgbmLH7tWrS+kiSeAY8qQcjHNQTL5W6JxlgefrTApyTtIHQGgBi4Jw49+Kk2D58Hr0pcCSNR0de47ikCkknBxQA4wheS2AeKRWPllWPPf3p2MxYx82T1pqj5HLjA6ZoAYVaKRZEJDdcr1r0XwH8Wdc8MSQJJM9xbA8xuxPFedAqI2AY8YxmmhdwOe1AH2V4e8c6P42RJbNlh1Ar88RPJrfVGK+WT0FfEmiaxd6JfRXdnK0bxtuBBr6x8C+Lrfxn4eW+s3H22DCXMI6g+v0NAGprpf8As1o5F3kHK8ciuXhkVo1Vs7/eu0GJPlc/MPX0rD13TWVWktfrgCgChaXj2N2lxb53r19x/hRT1jkmhLyQ7EUcHPFFAHVwxyzSeSM72645xXRRRR2dqEBACjJP0qCxt1tIyTzI/JNErgyIjEbSRuHtQBvaJAIrc3k335BlR6LWf4x8YaT4Q0iXUtYnUMAfKiz87nsAKwvif8QLHwT4f+2XGHuXGy2gB5Y+v0FfG/i7xNqvi/VHv9YnaQ/wIOFUegFAF74heLdS8eeJ5NW1NsRj5be3BykK+g9z3Nc1qG4RELw57ilUsenTHapIgJHhLMNwlXg9+aAOi+KG20/4RjRowFjtNOSWQDvI/wAxz+dcaPatvx5cy3PjbUpLj7ylUA9FCgACsMnP5UAOKrsLFhkHp60zjNHUdaOB3oADjAweaTHTr60uec+lAFACkHNIM4z6UHIyRTlYDoBQAo+bk0u0Z3E9KQP60h5PT9KAHdfwoxkYNJjn3FPXqM/hQB9B/ss3zN4d8U2J6Wjx3Cj/AHgQf5CvZNOtRc4kC4QjJB9a8K/ZWV5L/wAYxJ0exQ9O+44r6HsIxbWMCDqVG6gByKI/uAkCpSB14xSOu3ntTRjqOlACFQ5IzkY4qg/7uQRyDr0rQUgnHSiaMTxYIwR0NAFTyEBB65qxDGY+g6/yqONWDgMen61aUkEZPA60AcN448DQa4purZRHdDqMcGvL9X+GLWGnXWqXsiIsecoBz04x+NfRn8OM8muY8e6dJd+FNQEALOqliB6fSgD40vYgk7bjwTmq6BlLqWxG45HY1t6/ZmB8leT1HpWMudjrjOP5UAVipAyoyKekZOwofnHPHanqqy8Z2kVHjB9D7UAJIuXYkfMTk8c5pCS0GwkYzkVKCPmMnJI4qEkKdrDIzQAgGFyOTSqAMc8d6kk2Dy2jPDDkH1pHGRwPmJ5oAbcLyuBjC80yaUvDGm0bR3qadvvIgwM9TTEt5JQGDKozjk0AVmx2GKcRiM+p6VMIo4w3muHI6bajacH7gwB7UAVzyK7T4KeJm8K/EXTmkkIsb51tLhc8YYgAn6HBrjSAWLdMelQXBKhZE4kQhlPoRzQB+h+oaNFLPLAuEmAzG3rXJyNLDK1vdLskU4YY6+9dB8PfEQ8Z/D3Q9fiKm6aECdV7SLw4/MZ/GrPj2xWXTV1SHh7cZf3XvQBwupWBkjYRMfZQeMUVdQ5VGU/eGc0UAdSwznHJ7VXhaOJZ7y8YLbW6GWRj0AHNaGnWclzH9qyyRdAB3rjPj1et4f8AhNrFxGCPtIW13A9Nxx/LNAHy58R/Gd5478UzX9w22xhYx2sXZEB4/E1zqkKTtPtUUIEcC9xjnHepHADZ6eooAVgY2DcYNRXOI23A9GDZ9MVKpycN9wnJpJxueQ9QfbtQBp/EBAvigToSY7u3imU+uVGf1rnxgHv6c11HiRF1HwToGrRj95YltOuPrksh/L+Vcrk9yKAHNz0/CnBiFK9FYgn8KaPu5pe4PagAPB9/ek9KPQ8YoHBBJ+tAAaM4HNAIz1zSDp+NADx0pOhzmkz0oB7HrQA7JzkU9Pug0wYyOKfI22It37UAfR/7IliVsvFeqSJ+7fy7ZT2JAJP8xXtcQPlhn4wa4/4DaE3h/wCGemW86lJr4m9lB/2h8v6AV2MjEs0aj5l9f50ASFgQQfWouckE8UmDsG7g0/cMYx0FACL6fhUynpzxjmoVPfvSjPc0AMGftDBulSY2kHJI9KY/3w3bpUm4EZHpQA/duBx196khx5bhlDKwwwNV1JAxgdal8wgEqN3sKAPnj4v6PYaRfSTGE4kOUUfSvEbm6IuXiVQFb+VfVHxlsdITw3Pq2tTeXIq4hjDfM7dgBXyhM0LTvIgc7jnntQAqoC64fkVPLDEUkktmL45KnqDRJHHFar5cgkeTrj+Gqyu0Tqydc88UAShBgFien5Uy3WSa4EW3JbvS3kqNdtJEAEYZHsa1PDdnJcQXF5ztiB5oAy7hPLlKkfMpwRmofNO/cVGccc8Uh3u8jMH+Y55HNSSsrBRtKkCgCu5Z3y3WkJI45Ap7ZByBke1DhU9zQBHGMAg456GkCEjIxxzg0A85PShFY4CmgAQF42Y9qibBqaRACqxtlQOaZjCEY5J4oA9D+CvxLu/AOpPBKzSaPcODJFn7p/vD3r6/bW7HWvB91PazJJa3VuWjYHPUdDX58yjKkZ59K9w/Zv16e4sdX8OzSFlRfPhyeg6EfyoA9k0uQmxhQ8uqgZ9aKz45XhnRQOpxiigD24RLBbRwRDgAKBXjv7WdzHbfCKS1yBJc3kMaL64O4/yr2J5l89VyMfWvlT9rvxEL7xXpmgRPmOxh8+UA/wDLRzx+gH50AeEx8ABxwBTsAjJpM4zkZz+lNYcYzxQBIMAYbPHaljOWwfuGm4JwQOgp0RGfSgDZ8NRi++2aE8oS2vwDHuPAlX7p/p+NcxNBLa3MtrcqY7iJijqR0Iq4CwIZGKspyCDyDW5fvb+JbPzpyIdZgUBpe04A7+9AHLdRR3zQ6vE5SUFSOxoJGflNADh0pC3btSA880meKAFxQDgYpvTPNH0oAf70q84HNMBzUiEDJZgB1oAcq5+ldr8IfBs/jbxra2ojY6XaMJr2TsEHO36nGKyvB3hDWfGF8LfRrV3XI3SsCEX6mvrPwB4Vs/h14YOm2q+be3LB7uYdXfHQewoA6iKYGUpEoSGFRGijsAMCnSOrMGIKt61l2M0rNcq64YnOa00z5Q3AdKAIWlXJ3sN3ShZVyeahmhR3DnOQal2gHkcYoAnVlIBB5pxwRnvUS7ew61KTwMUAK2NpHWm9ueKeMnLUmBgnNACkZWkedIYWeQglVJ/KiR1ijDE9O3rXN+K5Zo/D2rXcW5QltI2AOmFJoA+a/jR4kuNf8UyQNJvtbT5UUHgHHJrz3DEEKpqyZjcTPPIxdpDkk96ilQhzjOPUUAMRNqNswCexpBFcMQqIGY+hp3lhvmJ+Ud81CNxJ2OQfXPagC1qUElp5EBizNKBt75zXU+JY10HwvZ6Qj7NUlbzZ1U9FPQVqfDHSE16I3V0jOthko56ZHNcr4qae+1u71K4BErvgJjoKAMhy5VVLfOOtROxON4B45NSSRAAMzhi3JA6iozIGJAXnoPegAYM6gjAXocVG/wDrDnO3GTR8wB39D3zTMqqnzDjigBWXK5XmhvljC9DT7eI7GnOQg4HvUa5dgSevrQA3BCkkYHTINKpO75RlQM806VGU/N909MetKIvJTdcjbvX5R3oAr8kg+telfs3iaX4ni1gGWuLd1I9gM15k55IHQd69t/Y7s/tPxRv7phn7Np7EH0LMo/xoA+h38LiewfbxPEeCDzmiuz0uSOa4uQoG1WOaKAMWznlaO0w25sKfrXyB8exJ/wALp19JeWxGVz2GwV9baO6GGxYg70IUj1r5U/aS2f8AC8NXMZzmCHd9dgoA88BwwVQBng5prAb9vAxwKDtJBwfapLhGjmGVxu5BoAjQ9t3TrT2yoIYcHkGllMeQu0Bscmmb227ByPegAU9/WnIxiPHBoUMSN6kgelD8NgjFAG7o1zol/C1r4jMlu54juYxnB7ZHpV/VPhpqMWhNrWiXEOp6d3MbfOB7rXJFQ42kdOau6XqF/pjB7G8mgA52q52n6igDDlbyHKTq0bjqGGKaZoscOuK9O0r4jPaTKNa8OaPq8RPJmhAfH1rubTx98KLu23ar4It7aXowjiBH4GgD53M0eTiRcUnmIDw496+lINf+BN0679CMTHoPJf8ApWB4h174LW7Omm+Eri7nA+XDMik++TQB4fbq9xKIrSKSeU8BIgWJP4V7v8L/AIC3N/bwax44c2lk4DxWCn97J/v/AN0e3WvN5fF0lrJPJ4Z0u10OJwQpiy0gX/eNfR/7OWm6jcfDn+19b1Ge6l1CYtEJpC2xFJHf1NAHoej2+n6HpkVppdpHa26DZGiD9Sar3RMzqEbO3mpNW+yWFrJe6xqMNhZQ9ZJWwP8A9deQ6z8c/DlhdNDodrNfhePPc7FJ9h1oA9WtkHnMCRuPWrw6YNeaeCvivofiO6WC6i+wXTcKS+VY/WvSFVcAq4ZW5z60AMcj5hj3ojfjGOKfJEzMpBphjYrjIA9aAFxk5DYpytnIzz0quzqicsMiq8sjSAtEQMetAF9pljGC2e+KA+4EniqkCqUEjElumDUyK7ngHn2oAmZQzcjPoKuW6RuTFPEssMiFJFYZBU8EGmW9rKwUbfzqUoqF2kuYIsDnc4GKAPnrxh8AZLfVru50C8B0x2MiWzD5ogew9RXlfiHwzNpRdFYs6cFSMGvsTWfEOgaNCLjU9atYUUf89ASfw715H4u+IHwqvL13uory7fnc8EJAY/jigD5uZ2VgvJ9VApJoZWZY0hc3EpCxxqOSSe1eha78QvD7xT2vhfwnaWcT5Bubj55SPUelVvhxeyp4lh1C3tUuriBSy71yqeh/CgD2nw74ctvht8LIrjXk2TlGnuEHUuw4X+Qr5o1vXpdZv57ry0hjkOVjXoBXpvxU1fxJq1giS3xmhuXy0QIx+VecJod1uRJVijlIwAxxmgDHUFsMoJHcmkAG/Ctls4AAzXYyeD5NMs0vPEl9Da2kn3EjcMz/AIDpUMmpeHLB4xpdi0rLjMkhzk+uKAMQafeTqBDAwZjjBHStrRNE0Gwvo5/Ft0zwR/Mba3PzP7Z+tJ4u8SXepX8ctni2gEaoEQYyAOp965mZfOuN7EliPmJoAu+ILuC91Gd7FDDZBv3MfoO1ZbYAOSc04ZckDrTSyspDDtj6UATWMbS3I25aNBvb8KrXMpuJmdznngelSRTNDbSLExBk+ViPSotgUAt070AJjHU4r6A/Y81Oy0y58SidkW9uBEsOcDcATkfqK+fmUFgQSRXR/DZ7r/hPNLgsCRI8wJx6DrQB926zq0ejeHdRvAB5uwhFHVmPSivO9duJbkxpPIcbxwD6e1FAHeeCoEu4pTN96F8CvjH4v3Ml18XvE0kzEstxsH+6BgV9l+EWNrqRWQ4SZCuCeAQa+OvjVZNY/F7xDH/C0u8H2IB/rQByTPu4xtApxlynGcjoTzTZCMqCpAHf1oGwHbjIPegB0kiEK2AHHBNPMbFFkYbAemeM1NZG3BdriInA+TnvVd5Hn/1p5B4xQAisUJO72pUII+c544NMcDJUjnFLGvmYAHHr2oAl3KoIUcN1NNVhvKcle1P8iaVGwvKeh61ChKXK7wUzxgigCYupA4470jFHU59ahQoZAmDkkgGnqsSy7Gcn1xQBZt7hbEiZY42cnC7hkCop8GR3Kr83IxUbqy88FB92kU75OB+FAE1paPfv5MbDceADXY33jXVrHwpp3hqyu5LSPTt2HhYqWJOefpmuX0meOwv7e4uxmEMCUXqR6VoeNrdTcpqVtHss7jkDstAHXfEbUtQ8S+B/D00uom7iSLbKqtkCQf3vevJ9wXKthSOMGtbTNUuNMWSGFt9rMQWibkE+tbdvqnhQwudW0Wa5vD9wRylFoA5rQTPJqsMVnlpC3AXrX1z4Z8WaVo/huysvFurwWl6zbcu2WA7Z9K+bn8VadZW7J4e8M2+lytx9qaRpJB9Celc1cPJeyPNczPMzdWY5oA+5o/JvbNLvStRgu7U9JYnDAioXt5c5MrNntXyl8GvEd3oPjrTLBLiT+zdSmS2miz8vzcA49a+up4xbXJgKFlBwGoAz/I/eBZFYZ6cU7ygJcR87euKzdc1bWPDmmarqVzbLqkcRVrS2gX58Hgg1taZf/abGynubCS1muYxI8TclCRnBoA5jxF4oTRrmMeUXJ+8ue1cP4h+Kt6lyosAkaY4wM16J4r8MR60paOXy5R/ER+leF+NfAms+Hle7mjE2n95U52fWgBvif4q67KgSC+eJjkEpxXmeoaxf38zyXN5PI7cks55q9daLeXFuZ7WOS4TPBRc1hXNrfW6t51ldKB38o0AI8hk/1jlz7nNQSSIgJyPSomaU4RIJi3YbDmvW/gb4FW98Qw6r4htPOtbcErbOvyu3bcO9AHOeC/hd4q8aRCbR7RYbQnabi5Oxfw9fwrqfG1zpnw90UeCtBuvterswl1K/UYAyP9Wp9K+n4XmmZVCJBbpwscY2jFeI/HT4TWkcc/iTQhIGcb7iPOcYHLCgD58nnuJJAWnkCqMg7qie8nuPLSV3dVPDZ5FQSMC3ByRwac+75QhAA5xQBNIW3FbsyPGcBS5yBUDIyZ242jgEVq6fqdqWMGrw74GGN6/eFX77wsUsmvtFnF3aqu91By0ftigDDmy9vHI3UMV61XkOQCTjP41ammtm0O02Ov2rzZPNTByq8bSe3rVAN8vB464oAVCVAdTkk4qOXr7+lSICo3AgkDjnvUbBg3OSxoAnuoYhY280DbmwfNH901W3kkHrVi1m8h3BQOjrhwahlKF/3YwvpQAPg84wBXrP7NnhuTUPEF/4ieNmhsEMUJxw0rDH6CvKrWzutTv7XTdPjM95eSLFFGvVmJwBX3x8NPAdn4H8GadokIElwP3tzL/flP3j9Ow9hQBwHkTNq8cNxx5YLOcUV0OuhR401BIvuRxKOB0bmigDoExHMpVTkHrXzn+0/wCHHsddt9fjBMN4QjN6MB/hX0/pkIuhM23JU4xXGfHzwr/a/wAKdYEahpbNftkPqNvJ/TNAHxipO0YGVNOZkOMcEelVbaQyWsZz1HIqwqho/lPzCgBdwKnJBJpjNtbByPShsIDnrQ52AbgTnoMUASXDp5x54KikWQhSq5A9u9Si7t3iUT2udv8AGDg0Rw2TJv8AtDRqT0IoAgV2Afa5XHFTLe+YsSXa70Rh8/cVY1C20yHT7aSxvmuLuQnzoymBGO2PWqGI/LI35+lAFvV7VbK+zBKJ7ZuUlUcc9qrRrjL44p1vcpbgwXB327+v8B9a0vGHh3VvCGq2+m61CE8+BbmB0YMskbdCCKAMtDvLAN14FJEwjY5XdwRketCpsQ8fM36U9IgCPMkVVPPHWgCO9IEO5jwF6V6BrAFt8I7I3EZZ5mBjJ6gZrgZQZ5re1toy0krbV716F8RpYrbwrpenGRJ57dAlwiHmP0yKAPPUmACNgBgO9Inzz7nIAz2pYYoHJzIy4Xj3oVECtIkgbHGDQBLbSv57hiCjDoaRztDOwAGeAKjjKg5U4xXp/wACvh63jjxIbu7Q/wBk2bBnJHDt/doAPgt4GvdS8T2Ov6lA8Om2Mi3EZIx5rjoBX1D/AGoLkSPJDIpPOStdJbWVhp0KQQQLiNQqqF4UDtT3mj3ojQo0bjBAXpQBykN6qN5Bjx5gzvPeo5NRu7mYQ2qqFjwGc1a8W6U0EB1LT/mgiGZoevHcj6VU0VYmsDNCd6SnINAGgu3HzfOalaG0vLaWz1G3SW1mXY6EZBBqJeoAqUE7uKAPlb4r+Cdb+G2tefpd7O2g3jH7PMpPyf7De/8AOuTtvHviyytzHb6q5i7iRA4/UV9leK9Ai8W+DtV0W6VS00LGBmH3JAMqR+NfCN80kNy9iB88DtFJj1Bwf5UAdr4d+KmtWmoRS6illcYb+K2Ubh9QK+hPAXxH0PxgLq3tootOubaPzJlbAG0dSDXx5dlbdW3Dkc5r1vwN4H1C1+G+veJrgNbxz2h8ongsuc/rQB9T6bNaahYpcadPFcREYDRsCK87+Ofi+x0bwVfaRBdo2rXabBGjZKqepPpXytpXiHXre12Wep3dtDjG2OQqP0ps8k02Jrq4aaQ9S5JJoApKFVAGUbgPm+tMkRQCxx7Yom3mXcSNp61E8hBwp78CgBQoY5KnAHOasaTqd5o9wbuxmKv90qehB9RVUuwiYc88kmk3fukU8dyaANjUL+yvJFZrJEZ1yxTj5qitF0idJPtHnQOqEoF6MfesyPPX9c059vl46knr6UAJLAUiEgG4E/w81EJCxBPGKckjJI+0nBHSmiYSELKq4z1HWgBEIJJLdaib92GJHA5zT5P9ZtU4ANMkjknuI7aL5nlcIuO+TigD6F/ZF8Ere6leeN9TH7iwZre0UjhpCvzP+AIA9z7V9OaTfSNZ3ep6hiKJdxUE/dQVl+CtBtfCfgjRtAsUGI4FD+rORlmP1JNZfxG1GPba+HLckGUCW4K9owen4mgDmdOklnkub6bh7yZpRn+6eg/KirEUqDaMDaGA6dvSigDuvD85h1iWByNs6bl+orfvYoriGWzuUDQXCNGwPQgjBH5GuHummt5Y5jkPC+9D6+orrmmTU9Lt7u1bIyJVI9uooA+APHXhS68CeN9R8P3hLJE/mW0pGBLE3KkfhwfcGsiSQ+btUYJGOK+t/wBqnwK3ibwZF4h01AdS0UNKwC8ywHl1/wCA43f99V8fpceZCHTqf0oAuIYPJxdkhs4BWpZba1ZS0F0Wwo+Vh/Ks+GNnkIZgPc1NaQMbuPcwKckkelAEcbcYYfL+tSMQxYkDb2FIoWV5CjbcHjNNkyhG4FgeOO1AAEVAGAwfalJQOABy3Sp7LT77UI5DbRERKMs54wKuRJp2nIBO5mnOM7TkCgCtbaRfapcyWdraySyICXwOFHvSapf6hdzW66jeS3TWqCCLzWLeWg6KM9q6TxJ4wC2CWnhmL7NFKgW4lAw7HHIz6VxSACMbzlx3J5NAFrcHB2EqRyQT2psTJGRIfm284PSolcnL8YPFDnbGFIHzdKAOj8KXdnp95/ad0od05jU+tZdzqU82qXV/J84uWJZD0IqnGA0O5GPHUHtSZITdnjtQBJIgAR0/1R/Q+lLleNo68Ee9RxPiJ4yPlY5xUinEB24DA96ACSM8RxAvJIwRAOpJ6V94fCHw4vg/4cabZeWFuhAJZ+MEyNyQfpnFfLf7PPhH/hJvGg1a/iJ0nScT7iPlklB+Vfz5/CvstCz6ZGx58wlzQBDGxkHz5DHk1NtBTaPXINMhXgg889auBQY2TI3cEAUAV4XSKURtysuVKnpXIafEum6vf6IoIWNvPhB7o3P6HNdc6sjh8cj1HSsPxjYFrqw1S3YrcKPKYjup5oAcowSMc1JGOpOMCmWitKw9T949gPWvP/G/xl8K+HLt9OtZX1K7jBDm3IKBvQt3oA6vxl4jj8M+Gb7UGYef5TLCpP8AERxXwwuRcXFxOcyyyM59eSTXfePfiFqPjO7BlUQWkQIjiU+vc+9cFOQH5NACGIzyRREBw7AN9K9o+KHxHh1bwvaeD/D8mLOKCNZZlG3O0fd+leMWztArSvgMRhPpTEPkncTjtnuaANWHTL6fw8t/bW0k1jFJ5TyxqSFb39Kpah5lp5YlXCOPlb1rpvBfxC1bwhpmt6PpkVvNYanGdyTLko5GNw/CtTwhqGl+LfDcvhnV4YodUTJtLnGCzehNAHnJJkDEg7R3prGMRAn72au6rZz6ReXGl3SbHgbaxPes+R+AB2FAChuN2TmlG6WNUiTdID0FMVfNIUAAActS2c8ltewzQNtMbA59cGgBYV3OY2YIzHBJ7Gn3MfkN5RZX2j7y9DUmr3f9panc3XkpH5jZ2xjAFUskbe/tQA0kliQKQ8fMeMVLKQG3QfdHBzTrm4WbYRGqMowcfxUAQMQcHnmuk+FulSa14/0m3jXcscwlf2VeTXLzMRhVBLk4UDqTX0z8IPBA8JeHTqGoKP7Xv0DjPWGMjIH1NAHtd/4mSx0+TUCA0qjyoI+7HpXGQxzGSW91BvMvrk7pX9B2UVUsn/tLUg0zjyrdSFXsD61pSTJM42MBAuSzepoAZId8OIU3E/Kg9T2orf8AClmsobWNQVYtOtQWiU/xMO9FAG83lzxHGHX6VjeD9UfQ/ElxomoPizvH32bHor90/HqK6690dZZPPsXVGbkqPut71yviTw/LdRCWWN1dBuDIeUI6MKAO8kEZU284Vo5AV2sMhgeoNfCnx28AN8PPHEi2qH+xNRLT2hHSPJ5j/D+WK+y/DGrf2rpwtbqVDqUK4J6b8fxD+tcx8aPC8fjXwTc6dJEp1W2Pm2577h1APvQB8NAF/m3fKvT3q3aXCxeYDkKyEAn1qOe3nsL2WyvImjnhYqyMMEYqMyBYwXQMc8LQA2KNpEHHHr2rV8NzGzv2Eqxy2xG50POR7VkPcM2R91OwFSWOU82YHaQuBnvQBZ1DUrq4up1jcxW7Z2qnAx6VmghSQenvT4yWG0HB5OaiZlz8wJFAE5kwoAI/Cm5GwY5YdqhVypygwfelwxYMFwPXtQBYKl0dgCoTkjFI+z5QCT3NWNCHnawltI42XClCT0BxwapSqYZZIWwdjFcjvQBakAi2MMDcOfSokYIxJwR0xTvkaJFkYh+ox6U0DeCd3zDsaAJMEMHGGANX9C0u78SeILTR9KQtc3UgTj+EZ5J9gOayy/yhEDGViAoHc19S/s//AA9HhjTBrmrJjWLuM4RxzChPT6mgD0Lwl4YtfCugW2h6Yo+z2wHmyAYMzn7zGvQtirbRKhwAgwK5ixv1/fPL8iq2Oe49a6sorwxmN12beCfSgCDY6KSFDd8jtVSGZWu3bawkHCkdKS/1i2sSbeLM85HKqeB9azYtWuYysn2dCvdR6UAdG8TOu49x3qprUAbSl3kERMGJ+lT6ffQ6lb74Thh95D1WjVnSHS7lpz8hQjHvQB5l8Q7zUI/B+vzaNuCx2bklOuMckfhXxjYhPJDgZY85r710YwpZPa3cavbzRmKRT0ZTwa+Nvit4Nm+H/jS405stptzmayl7NGT0+o6UAc0ZAEywJPoKrPG9w5xhEHXJoLNgEHCmmDZG5aVmIYYoAZIzggj5lXgAVr6fptv/AGXPqGp3yKQMQwLy7N9OwrE8xduyHIJ4pEikIIKlsdaAJIX8pNw5OetallpFy9r/AGwsnlxQsHZ0PIx2rJ2kLwVI6V1PwzuDP4h/su4BlsJkZmj7DCk/0oA1/E+r+G/Fmj200MFxBqkKBbiZiMSH1ri59HYAG1uYZFIzy3NaVjZ2F3q99b2FwIlZmVI5OMnsK5+5tZ7O4dblHTDEZ6CgC5c6ddQokSxKxI3FlPWqbQTqx3ROO2AKZ58xPyyvx056VYh1G5inE4kPy9ARmgCBpVRWiXPvkUyLczY98VbScXsxE0YWZuQyjiqzsx4yPlOMYoAcse2Rwx5HYd6jZgqnI4pWO45YgY7113wx+H1/4+1YrHmDR4HH2m59B6D1NAHVfs/+Bf7Z1E+KNVjB07T5MQxOvE0mOPwHBr3LXL5RG6lsyMCSey+gqeRLTR9NtdL0uIRW9ugjhjUdcfxH396wbbTbzXNTWztxuuHOW/uqvqaAKmjebOwWFtoyfMc9B7V3vh3w9Jqrx7h5WmxYYtj7+K6DSfB2l6DZpJeShlQZYueM1k674he9iaz0tfs9ipxvQ4Z/YUAQ+J9Ui1WZdNsP3em2xw23gSN6fQUVmIUSFVjAA7CigDubO5uLKTEEm+L+41bdlqkNxlZMRv6HvXPbtuccYqN3WXAIBxxmgBPGGjmCeDWdHIinhbMgTow9cVdgu11+yDRnyNSiH3fX/wCtVGGeWBJYS26Jxgg1QKPHMkkDlJY/usP5UAeY/Gj4Zf8ACYQSalo8C2/iW2/1sP3RcIO496+Yple2ne21KGSC4iJUowwQR2NfoG8ia1CHjYQ6jFxnpmvPvib8OtL8c2DpdwrYa9EpMN0i4EhA4DeooA+NxHv3AnaMZGe9OnkQxReWSQowTWv4s8Ja54RvFt9ctXQ5KiQDKsB3BrIEiBhFwUIz+NAEPOMgEipbfaCksy7o92MetMCSCYIOOeakvOXMeQYwOPrQBFNtEr7Bhc8c0/dK9gq4BUMTjuKjXDFl6k9/Smq8isJEbAPGKAFhfy5UkDYIP40oODnG7cSaZIgyMY9SKd5ixnezAcdKAHy5LiQj5RwMVGZCXVYgXlY4Cjk810Xg7wXrvjK4WPSrSX7MW2tcOuI1+pr6U8CfCXQvBqRT3ES6hqo+YzyDKof9laAOI+CvwuazMPiPxRbsZwd9raMMYIPDMP6V9DWSyTAy3DKEUbmboB7VXtrG4vJBLJkRA9TwMVJNt1i+/si0if7JHjzph0PtmgCvbLFqOpJ5bbolbhV6E+9dNqzSabpM0xjJ2LwBzitDT9Nt9LhWKyhVUHX1q47IEPmY2nqDQB5/YmGSJJofm8wbt9WjIR15WtLUPDwiLS6Z8iElmjzxk+lURpt+VxCFL+hoAqxXYstQgnhJE0rCMp0yK63VIjPaMsg+Q/jVHTtBgtblL28cyXAGACflU+1bsmxkKvyrDBFAHFW1tOSVcDCngjuK5z4peCbXx94Wk02TbHqUALWVy/VH/un2PSu11HSjp8ovLWSRogf3kTHIA9qS6t0uolu7RiwAyQDz+VAH5+anYXeiatPpOsxtBeW7lGRhjp3+lRTLiNd3zA9K+xfin8NNK+I9gCNtn4ghTbBdAY3Y/hf1HvXyD4h0bVfCutzaT4gt3guIyQNw4YdMg9xQBXhxHbzNIArtwlV4/OmcRISzNxgHrT3iPlY5Kg7gT3pgJiCyKcSfwn0oAZIjqxQqQVOCD61b0W+m0/UHuYG8twpXI9xg1WkLPl2bL/xGnWrKrsrKG3DGfSgBqACWWfcRKSWXHc1cTVZxEsF4ouIi2fm6rVAlQRgk/UUjffDY4BoAval9hVttnC8b9SCc5qi284yBj3qbUnDXG5BglR+FQKCVyTmgB1sfKlLljgClG5WLr8wbnmkiAJwTgHv6V1Xw48Caz8QtcGlaGu21jIN3euPkhX19z6DvQA34feCdU+IniOLS9IQrbpg3V0V+SBPU+/oO9fX6aHpXgbwjHp+lx+XZ2yhS2fmmfuxPck1seCvCGl+CdAi0bw/EsUaqDd3RHzTuByzH/OK5/wARSnWtRSJDjT7Q4PP32oAzLaCebMz4DyDC57A1s6Df23hi2dbZDc6jM253x29Kgxu+RCFTpgU140jUsRk+3agCXVb+81cr/aD7Yhz5S9D9aqqEyAigAHHFV5LhF5c89ADTHkJRmRfmx0oAttIFHG3IoqjbpI7gHAOMnPaigDrb2+kWI7UI560lpItxDuR/3g6is5LmVWIb5l96toqSHdAfLkAzwOtAGjgYzISQRg1Gygt34ohlMi7JBtfHboTVhkO3PBHHNAFPZsdWTKspzkVea8S5jWK7HzdnFR7Dxxg1FJFldpGaAKmsabaajaPZarbx3tnICMsMkf4V5L4g+A2iajI76Tfy2Up5VX5X6V7AFkgO08ofekMUU2A4II7igD448Y/DnxP4VnlW6tXubdW+SeIbgw7GuPmMsIYzxup6HK197tZyjjcJE9GrntW8DaNqZL3el2zluWwAM/lQB8RLcqqlVzjqeKaspddsSOxzn5Rmvs23+FnhOFiy6LETjByxP9a6DR/BWh6e6G30axjC8giJSfzNAHxz4X8CeKvFcyJpWkzlG/5bOu1R+Jr3bwF+znaWLRXvjG6F3IOfscXCZ92r3M3fkgRW0aoq8cACq8s1xJj0PfNAD7O1sNLs1sdOtora3jACpGoAxUF1LtHygMfegJMeSuT9RQ8coGBEDnvkUAZNzPeTMY5LlkjGPlTjj0rW0zULnTLc28EC7mGVcd6RbXmSN0ByOtTIrpCEjj3FR/ER0oAoT3viszs9rfW4VjkI6ZAFXNI8W6lbyi08UWKEO2FubUZT/gQ7U6Mzvn5MfiKGtpogzMPMU9QxFAHaW00EoBtpldcfdBqWVXx+62hj1JrjvDunOt3PeWzsoTqmeCfTFdDq15LDpiSxJtmkIUA4OM0AOv7q1sYvNv5gzDkL7+wrm7jxfqElx/oOlr9n7PM+CfwFNms3Lia5y8mcZJzzSyRSqGYIAgGSTQBbi8RyspF/bBFP9zkYrE1TUvs16JNIkKSMMmNuFNP+3Wilo2lww6/KT/SsbU5ry5Dvp9nbjA4eVzk++BQB0un3qamqm4Tybkd16Gsz4i+DND8aaF/Z3imPyZE5t75B+8jPt6j2rm7saotvE98IhGB86wsR16Hrz6Yqa3vmtzHE6vlfmSRjuZeO3pQB8ueOvAPiHwRcSRXtvJe6ST+6vYFJVl7Z/un2NcXcXMTFfKXIA5zX3vFDNcW22BUuYzy0UnAYHr7CuD8W/BLwt4uV5NOs5tG1R8ASwEGMsf7yZ/ligD5NWMgYTncO9Mj+SRWAyO+a9d8Q/ADx7ocLS26WGpWyA5aOdUYDtkPivNr7SL6y85b6BoniO1wJFPP4GgDMlUod4HyHpUf3mwWOT2rettGuLyCSeKIm2gQNJ84GATgd/U07RvDuravf/Z9J09JZj93fKq/zNAGJLidDKchl+TFV1ZFBVmJYjAUckmvcPC37OfjLW545Nfms9JsWOTskEsmPYKcfrXu/gT4IeEvBcoubezbVdVQblnviGCn1C9B/OgD58+FHwH1fxakWp+Jml0bQiA6bhiacZ6AH7ox3P5V9YeG9C07w9pUemeHLGKw02IDLKMNJj+Jj3Pua1jFKIHm1NkEaDdsTJC1x+r69cauklppmIbEEq8vRiPYUAS+ItaFwDp+luNinE0wP6VhCNUXYmAo7CpILQQxLFDjb3JPJokAjU7mUMmT0PH6UANRsLyeh9Kz9QvyoaO3XzJicfSpmk851RJlVT14Of5VQvdQtNNRgx82bd/dIzn3oAgsLGaQ+bdszvnpjgCtFhHDktwNtYcviCeUMlsqIe/Xg1QgsNT1cu63AKEgE7iAPwoA0tX1uK3UJblSzDgA5JoqG+0vRPClouo+IbppHALLGiM2fYcUUAf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A CT scan shows a thin-walled gas-filled cyst in right upper lobe.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_8_32911=[""].join("\n");
var outline_f32_8_32911=null;
